"keggcom","disease","text"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_363448003","Context: Vitamin D3 might benefit prostate cancer (PCa) patients because prostate cells can locally synthesize the active hormone calcitriol."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_399068003","Context: Vitamin D3 might benefit prostate cancer (PCa) patients because prostate cells can locally synthesize the active hormone calcitriol."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_93974005","Context: Vitamin D3 might benefit prostate cancer (PCa) patients because prostate cells can locally synthesize the active hormone calcitriol."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_154531004","Context: Vitamin D3 might benefit prostate cancer (PCa) patients because prostate cells can locally synthesize the active hormone calcitriol."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_254900004","Context: Vitamin D3 might benefit prostate cancer (PCa) patients because prostate cells can locally synthesize the active hormone calcitriol."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_263847000","Context: Vitamin D3 might benefit prostate cancer (PCa) patients because prostate cells can locally synthesize the active hormone calcitriol."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_41216001","Context: Vitamin D3 might benefit prostate cancer (PCa) patients because prostate cells can locally synthesize the active hormone calcitriol."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_279689003","Context: Vitamin D3 might benefit prostate cancer (PCa) patients because prostate cells can locally synthesize the active hormone calcitriol."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_30281009","Context: Vitamin D3 might benefit prostate cancer (PCa) patients because prostate cells can locally synthesize the active hormone calcitriol."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_197979000","Context: Vitamin D3 might benefit prostate cancer (PCa) patients because prostate cells can locally synthesize the active hormone calcitriol."
"https://www.kegg.jp/entry/C00072","http://www.ihtsdo.org/SCT_64572001","Ascorbic acid can be used as a nutritional supplement for cellular therapy of bone-related disease."
"https://www.kegg.jp/entry/C00153","http://www.ihtsdo.org/SCT_131143000","Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes"
"https://www.kegg.jp/entry/C00153","http://www.ihtsdo.org/SCT_189759009","Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes"
"https://www.kegg.jp/entry/C00153","http://www.ihtsdo.org/SCT_254818000","Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes"
"https://www.kegg.jp/entry/C00153","http://www.ihtsdo.org/SCT_61814002","Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes"
"https://www.kegg.jp/entry/C00153","http://www.ihtsdo.org/SCT_414916001","Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes"
"https://www.kegg.jp/entry/C00153","http://www.ihtsdo.org/SCT_154776002","Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes"
"https://www.kegg.jp/entry/C00153","http://www.ihtsdo.org/SCT_190963004","Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes"
"https://www.kegg.jp/entry/C00153","http://www.ihtsdo.org/SCT_414915002","Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes"
"https://www.kegg.jp/entry/C00153","http://www.ihtsdo.org/SCT_5476005","Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes"
"https://www.kegg.jp/entry/C00153","http://www.ihtsdo.org/SCT_154672006","Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes"
"https://www.kegg.jp/entry/C00153","http://www.ihtsdo.org/SCT_190323008","Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes"
"https://www.kegg.jp/entry/C00153","http://www.ihtsdo.org/SCT_190384004","Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes"
"https://www.kegg.jp/entry/C00153","http://www.ihtsdo.org/SCT_267468009","Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes"
"https://www.kegg.jp/entry/C00153","http://www.ihtsdo.org/SCT_44054006","Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes"
"https://www.kegg.jp/entry/C00255","http://www.ihtsdo.org/SCT_93880001","Riboflavin at 200 and 400 μmol/L significantly enhanced cell growth in test lung cancer cell lines, and at 400 μmol/L significantly increased the release of interleukin-6, tumor necrosis factor-alpha, and vascular endothelial growth factor."
"https://www.kegg.jp/entry/C00255","http://www.ihtsdo.org/SCT_363358000","Riboflavin at 200 and 400 μmol/L significantly enhanced cell growth in test lung cancer cell lines, and at 400 μmol/L significantly increased the release of interleukin-6, tumor necrosis factor-alpha, and vascular endothelial growth factor."
"https://www.kegg.jp/entry/C00255","http://www.ihtsdo.org/SCT_154485001","Riboflavin at 200 and 400 μmol/L significantly enhanced cell growth in test lung cancer cell lines, and at 400 μmol/L significantly increased the release of interleukin-6, tumor necrosis factor-alpha, and vascular endothelial growth factor."
"https://www.kegg.jp/entry/C00255","http://www.ihtsdo.org/SCT_187875007","Riboflavin at 200 and 400 μmol/L significantly enhanced cell growth in test lung cancer cell lines, and at 400 μmol/L significantly increased the release of interleukin-6, tumor necrosis factor-alpha, and vascular endothelial growth factor."
"https://www.kegg.jp/entry/C00255","http://www.ihtsdo.org/SCT_269561006","Riboflavin at 200 and 400 μmol/L significantly enhanced cell growth in test lung cancer cell lines, and at 400 μmol/L significantly increased the release of interleukin-6, tumor necrosis factor-alpha, and vascular endothelial growth factor."
"https://www.kegg.jp/entry/C00255","http://www.ihtsdo.org/SCT_93880001","Riboflavin at high doses enhances lung cancer cell proliferation, invasion, and migration"
"https://www.kegg.jp/entry/C00255","http://www.ihtsdo.org/SCT_363358000","Riboflavin at high doses enhances lung cancer cell proliferation, invasion, and migration"
"https://www.kegg.jp/entry/C00255","http://www.ihtsdo.org/SCT_154485001","Riboflavin at high doses enhances lung cancer cell proliferation, invasion, and migration"
"https://www.kegg.jp/entry/C00255","http://www.ihtsdo.org/SCT_187875007","Riboflavin at high doses enhances lung cancer cell proliferation, invasion, and migration"
"https://www.kegg.jp/entry/C00255","http://www.ihtsdo.org/SCT_269561006","Riboflavin at high doses enhances lung cancer cell proliferation, invasion, and migration"
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_10200004","Folic acid (vitamin B9) rich sources are leafy green vegetables, legumes, whole grains, egg yolk, liver, and citrus fruit."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_155807008","Folic acid (vitamin B9) rich sources are leafy green vegetables, legumes, whole grains, egg yolk, liver, and citrus fruit."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_155817003","Folic acid (vitamin B9) rich sources are leafy green vegetables, legumes, whole grains, egg yolk, liver, and citrus fruit."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_155822003","Folic acid (vitamin B9) rich sources are leafy green vegetables, legumes, whole grains, egg yolk, liver, and citrus fruit."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_197375001","Folic acid (vitamin B9) rich sources are leafy green vegetables, legumes, whole grains, egg yolk, liver, and citrus fruit."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_197551000","Folic acid (vitamin B9) rich sources are leafy green vegetables, legumes, whole grains, egg yolk, liver, and citrus fruit."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_235856003","Folic acid (vitamin B9) rich sources are leafy green vegetables, legumes, whole grains, egg yolk, liver, and citrus fruit."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_266535008","Folic acid (vitamin B9) rich sources are leafy green vegetables, legumes, whole grains, egg yolk, liver, and citrus fruit."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_62857009","Folic acid (vitamin B9) rich sources are leafy green vegetables, legumes, whole grains, egg yolk, liver, and citrus fruit."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_412238008","Folic acid (vitamin B9) rich sources are leafy green vegetables, legumes, whole grains, egg yolk, liver, and citrus fruit."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_88566002","Folic acid (vitamin B9) rich sources are leafy green vegetables, legumes, whole grains, egg yolk, liver, and citrus fruit."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_190625009","Objective: Thiamine or vitamin B1 deficiency diminishes thiamine-dependent enzymatic activity, alters mitochondrial function, impairs oxidative metabolism, and causes selective neuronal death."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_154725000","Objective: Thiamine or vitamin B1 deficiency diminishes thiamine-dependent enzymatic activity, alters mitochondrial function, impairs oxidative metabolism, and causes selective neuronal death."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_267491008","Objective: Thiamine or vitamin B1 deficiency diminishes thiamine-dependent enzymatic activity, alters mitochondrial function, impairs oxidative metabolism, and causes selective neuronal death."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_35843007","Objective: Thiamine or vitamin B1 deficiency diminishes thiamine-dependent enzymatic activity, alters mitochondrial function, impairs oxidative metabolism, and causes selective neuronal death."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_36656008","Objective: Thiamine or vitamin B1 deficiency diminishes thiamine-dependent enzymatic activity, alters mitochondrial function, impairs oxidative metabolism, and causes selective neuronal death."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_190624008","Objective: Thiamine or vitamin B1 deficiency diminishes thiamine-dependent enzymatic activity, alters mitochondrial function, impairs oxidative metabolism, and causes selective neuronal death."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_190628006","Objective: Thiamine or vitamin B1 deficiency diminishes thiamine-dependent enzymatic activity, alters mitochondrial function, impairs oxidative metabolism, and causes selective neuronal death."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_399357009","Objective: Thiamine or vitamin B1 deficiency diminishes thiamine-dependent enzymatic activity, alters mitochondrial function, impairs oxidative metabolism, and causes selective neuronal death."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_191088004","Objective: Thiamine or vitamin B1 deficiency diminishes thiamine-dependent enzymatic activity, alters mitochondrial function, impairs oxidative metabolism, and causes selective neuronal death."
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_154671004","Glutamate production is diminished in an incretin-unresponsive, insulin-secreting β cell line and pancreatic islets of animal models of human diabetes and obesity."
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_191044006","Glutamate production is diminished in an incretin-unresponsive, insulin-secreting β cell line and pancreatic islets of animal models of human diabetes and obesity."
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_267467004","Glutamate production is diminished in an incretin-unresponsive, insulin-secreting β cell line and pancreatic islets of animal models of human diabetes and obesity."
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_73211009","Glutamate production is diminished in an incretin-unresponsive, insulin-secreting β cell line and pancreatic islets of animal models of human diabetes and obesity."
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_414916001","Glutamate production is diminished in an incretin-unresponsive, insulin-secreting β cell line and pancreatic islets of animal models of human diabetes and obesity."
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_154776002","Glutamate production is diminished in an incretin-unresponsive, insulin-secreting β cell line and pancreatic islets of animal models of human diabetes and obesity."
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_190963004","Glutamate production is diminished in an incretin-unresponsive, insulin-secreting β cell line and pancreatic islets of animal models of human diabetes and obesity."
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_414915002","Glutamate production is diminished in an incretin-unresponsive, insulin-secreting β cell line and pancreatic islets of animal models of human diabetes and obesity."
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_5476005","Glutamate production is diminished in an incretin-unresponsive, insulin-secreting β cell line and pancreatic islets of animal models of human diabetes and obesity."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_129453003","Thiamine is crucial for normal auditory development and function, and its deficiency may be considered an acquired metabolic cause of ANSD in infants."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_246199000","Thiamine is crucial for normal auditory development and function, and its deficiency may be considered an acquired metabolic cause of ANSD in infants."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_260372006","Thiamine is crucial for normal auditory development and function, and its deficiency may be considered an acquired metabolic cause of ANSD in infants."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_154722002","Thiamine is crucial for normal auditory development and function, and its deficiency may be considered an acquired metabolic cause of ANSD in infants."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_154730001","Thiamine is crucial for normal auditory development and function, and its deficiency may be considered an acquired metabolic cause of ANSD in infants."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_190595009","Thiamine is crucial for normal auditory development and function, and its deficiency may be considered an acquired metabolic cause of ANSD in infants."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_190608007","Thiamine is crucial for normal auditory development and function, and its deficiency may be considered an acquired metabolic cause of ANSD in infants."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_190678008","Thiamine is crucial for normal auditory development and function, and its deficiency may be considered an acquired metabolic cause of ANSD in infants."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_238106006","Thiamine is crucial for normal auditory development and function, and its deficiency may be considered an acquired metabolic cause of ANSD in infants."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_248325000","Thiamine is crucial for normal auditory development and function, and its deficiency may be considered an acquired metabolic cause of ANSD in infants."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_2492009","Thiamine is crucial for normal auditory development and function, and its deficiency may be considered an acquired metabolic cause of ANSD in infants."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_267409003","Thiamine is crucial for normal auditory development and function, and its deficiency may be considered an acquired metabolic cause of ANSD in infants."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_267495004","Thiamine is crucial for normal auditory development and function, and its deficiency may be considered an acquired metabolic cause of ANSD in infants."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_302868002","Thiamine is crucial for normal auditory development and function, and its deficiency may be considered an acquired metabolic cause of ANSD in infants."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_47563007","Thiamine is crucial for normal auditory development and function, and its deficiency may be considered an acquired metabolic cause of ANSD in infants."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_65404009","Thiamine is crucial for normal auditory development and function, and its deficiency may be considered an acquired metabolic cause of ANSD in infants."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_70241007","Thiamine is crucial for normal auditory development and function, and its deficiency may be considered an acquired metabolic cause of ANSD in infants."
"https://www.kegg.jp/entry/C00062","http://www.ihtsdo.org/SCT_414916001","Conclusions: L-Arginine supplementation affects zinc status in obese patients."
"https://www.kegg.jp/entry/C00062","http://www.ihtsdo.org/SCT_154776002","Conclusions: L-Arginine supplementation affects zinc status in obese patients."
"https://www.kegg.jp/entry/C00062","http://www.ihtsdo.org/SCT_190963004","Conclusions: L-Arginine supplementation affects zinc status in obese patients."
"https://www.kegg.jp/entry/C00062","http://www.ihtsdo.org/SCT_414915002","Conclusions: L-Arginine supplementation affects zinc status in obese patients."
"https://www.kegg.jp/entry/C00062","http://www.ihtsdo.org/SCT_5476005","Conclusions: L-Arginine supplementation affects zinc status in obese patients."
"https://www.kegg.jp/entry/C01673","http://www.ihtsdo.org/SCT_154521006","Calcitriol [1,25(OH)2D3], the hormonally active form of vitamin D exerts anti-proliferative, pro-apoptotic, anti-inflammatory effects and other anticancer actions in breast cancer (BCa) cell cultures and animal models of BCa."
"https://www.kegg.jp/entry/C01673","http://www.ihtsdo.org/SCT_190121004","Calcitriol [1,25(OH)2D3], the hormonally active form of vitamin D exerts anti-proliferative, pro-apoptotic, anti-inflammatory effects and other anticancer actions in breast cancer (BCa) cell cultures and animal models of BCa."
"https://www.kegg.jp/entry/C01673","http://www.ihtsdo.org/SCT_269595005","Calcitriol [1,25(OH)2D3], the hormonally active form of vitamin D exerts anti-proliferative, pro-apoptotic, anti-inflammatory effects and other anticancer actions in breast cancer (BCa) cell cultures and animal models of BCa."
"https://www.kegg.jp/entry/C01673","http://www.ihtsdo.org/SCT_254837009","Calcitriol [1,25(OH)2D3], the hormonally active form of vitamin D exerts anti-proliferative, pro-apoptotic, anti-inflammatory effects and other anticancer actions in breast cancer (BCa) cell cultures and animal models of BCa."
"https://www.kegg.jp/entry/C01673","http://www.ihtsdo.org/SCT_154513000","Calcitriol [1,25(OH)2D3], the hormonally active form of vitamin D exerts anti-proliferative, pro-apoptotic, anti-inflammatory effects and other anticancer actions in breast cancer (BCa) cell cultures and animal models of BCa."
"https://www.kegg.jp/entry/C01673","http://www.ihtsdo.org/SCT_254838004","Calcitriol [1,25(OH)2D3], the hormonally active form of vitamin D exerts anti-proliferative, pro-apoptotic, anti-inflammatory effects and other anticancer actions in breast cancer (BCa) cell cultures and animal models of BCa."
"https://www.kegg.jp/entry/C01673","http://www.ihtsdo.org/SCT_286898006","Calcitriol [1,25(OH)2D3], the hormonally active form of vitamin D exerts anti-proliferative, pro-apoptotic, anti-inflammatory effects and other anticancer actions in breast cancer (BCa) cell cultures and animal models of BCa."
"https://www.kegg.jp/entry/C00072","http://www.ihtsdo.org/SCT_389086002","Ascorbate prevents placental oxidative stress and enhances birth weight in hypoxic pregnancy in rats"
"https://www.kegg.jp/entry/C00072","http://www.ihtsdo.org/SCT_30869003","Ascorbate prevents placental oxidative stress and enhances birth weight in hypoxic pregnancy in rats"
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_129453003","Biotin and folate supplementation could compensate for each other's deficiency in the repression of LTRs in Jurkat and U937 cells."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_246199000","Biotin and folate supplementation could compensate for each other's deficiency in the repression of LTRs in Jurkat and U937 cells."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_260372006","Biotin and folate supplementation could compensate for each other's deficiency in the repression of LTRs in Jurkat and U937 cells."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_154722002","Biotin and folate supplementation could compensate for each other's deficiency in the repression of LTRs in Jurkat and U937 cells."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_154730001","Biotin and folate supplementation could compensate for each other's deficiency in the repression of LTRs in Jurkat and U937 cells."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_190595009","Biotin and folate supplementation could compensate for each other's deficiency in the repression of LTRs in Jurkat and U937 cells."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_190608007","Biotin and folate supplementation could compensate for each other's deficiency in the repression of LTRs in Jurkat and U937 cells."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_190678008","Biotin and folate supplementation could compensate for each other's deficiency in the repression of LTRs in Jurkat and U937 cells."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_238106006","Biotin and folate supplementation could compensate for each other's deficiency in the repression of LTRs in Jurkat and U937 cells."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_248325000","Biotin and folate supplementation could compensate for each other's deficiency in the repression of LTRs in Jurkat and U937 cells."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_2492009","Biotin and folate supplementation could compensate for each other's deficiency in the repression of LTRs in Jurkat and U937 cells."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_267409003","Biotin and folate supplementation could compensate for each other's deficiency in the repression of LTRs in Jurkat and U937 cells."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_267495004","Biotin and folate supplementation could compensate for each other's deficiency in the repression of LTRs in Jurkat and U937 cells."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_302868002","Biotin and folate supplementation could compensate for each other's deficiency in the repression of LTRs in Jurkat and U937 cells."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_47563007","Biotin and folate supplementation could compensate for each other's deficiency in the repression of LTRs in Jurkat and U937 cells."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_65404009","Biotin and folate supplementation could compensate for each other's deficiency in the repression of LTRs in Jurkat and U937 cells."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_70241007","Biotin and folate supplementation could compensate for each other's deficiency in the repression of LTRs in Jurkat and U937 cells."
"https://www.kegg.jp/entry/C00183","http://www.ihtsdo.org/SCT_156726002","In accordance, well-known microbial production bacteria, such as Escherichia coli and Corynebacterium glutamicum strains, have recently been metabolically engineered for efficient L-valine production under aerobic or anaerobic conditions, and the respective cultivation and production conditions have been optimized."
"https://www.kegg.jp/entry/C00183","http://www.ihtsdo.org/SCT_157257005","In accordance, well-known microbial production bacteria, such as Escherichia coli and Corynebacterium glutamicum strains, have recently been metabolically engineered for efficient L-valine production under aerobic or anaerobic conditions, and the respective cultivation and production conditions have been optimized."
"https://www.kegg.jp/entry/C00183","http://www.ihtsdo.org/SCT_203094001","In accordance, well-known microbial production bacteria, such as Escherichia coli and Corynebacterium glutamicum strains, have recently been metabolically engineered for efficient L-valine production under aerobic or anaerobic conditions, and the respective cultivation and production conditions have been optimized."
"https://www.kegg.jp/entry/C00183","http://www.ihtsdo.org/SCT_269324003","In accordance, well-known microbial production bacteria, such as Escherichia coli and Corynebacterium glutamicum strains, have recently been metabolically engineered for efficient L-valine production under aerobic or anaerobic conditions, and the respective cultivation and production conditions have been optimized."
"https://www.kegg.jp/entry/C00183","http://www.ihtsdo.org/SCT_367127009","In accordance, well-known microbial production bacteria, such as Escherichia coli and Corynebacterium glutamicum strains, have recently been metabolically engineered for efficient L-valine production under aerobic or anaerobic conditions, and the respective cultivation and production conditions have been optimized."
"https://www.kegg.jp/entry/C00183","http://www.ihtsdo.org/SCT_48532005","In accordance, well-known microbial production bacteria, such as Escherichia coli and Corynebacterium glutamicum strains, have recently been metabolically engineered for efficient L-valine production under aerobic or anaerobic conditions, and the respective cultivation and production conditions have been optimized."
"https://www.kegg.jp/entry/C00153","http://www.ihtsdo.org/SCT_131143000","Nicotinamide (NAM) is the amide of nicotinic acid and a predominant precursor for NAD(+) biosynthesis via the salvage pathway."
"https://www.kegg.jp/entry/C00153","http://www.ihtsdo.org/SCT_189759009","Nicotinamide (NAM) is the amide of nicotinic acid and a predominant precursor for NAD(+) biosynthesis via the salvage pathway."
"https://www.kegg.jp/entry/C00153","http://www.ihtsdo.org/SCT_254818000","Nicotinamide (NAM) is the amide of nicotinic acid and a predominant precursor for NAD(+) biosynthesis via the salvage pathway."
"https://www.kegg.jp/entry/C00153","http://www.ihtsdo.org/SCT_61814002","Nicotinamide (NAM) is the amide of nicotinic acid and a predominant precursor for NAD(+) biosynthesis via the salvage pathway."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_154774004","Glycine and four metabolites found to be significantly associated with regional adiposity were additionally associated with HOMA-IR."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_190976005","Glycine and four metabolites found to be significantly associated with regional adiposity were additionally associated with HOMA-IR."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_267511009","Glycine and four metabolites found to be significantly associated with regional adiposity were additionally associated with HOMA-IR."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_308125009","Glycine and four metabolites found to be significantly associated with regional adiposity were additionally associated with HOMA-IR."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_414916001","Glycine and four metabolites found to be significantly associated with regional adiposity were additionally associated with HOMA-IR."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_5476005","Glycine and four metabolites found to be significantly associated with regional adiposity were additionally associated with HOMA-IR."
"https://www.kegg.jp/entry/C00072","http://www.ihtsdo.org/SCT_13877006","Ascorbic acid and its relationship with periodontal disease are very well known."
"https://www.kegg.jp/entry/C00072","http://www.ihtsdo.org/SCT_196354003","Ascorbic acid and its relationship with periodontal disease are very well known."
"https://www.kegg.jp/entry/C00072","http://www.ihtsdo.org/SCT_2556008","Ascorbic acid and its relationship with periodontal disease are very well known."
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_35604006","Results: Glutamate taken up from the maternal and fetal circulations was primarily converted into glutamine the majority of which was released into the maternal circulation."
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_204507004","Results: Glutamate taken up from the maternal and fetal circulations was primarily converted into glutamine the majority of which was released into the maternal circulation."
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_206597007","Results: Glutamate taken up from the maternal and fetal circulations was primarily converted into glutamine the majority of which was released into the maternal circulation."
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_233815004","Results: Glutamate taken up from the maternal and fetal circulations was primarily converted into glutamine the majority of which was released into the maternal circulation."
"https://www.kegg.jp/entry/C00440","http://www.ihtsdo.org/SCT_205788004","5-Methyltetrahydrofolate, SAM, and SAM/S-adenosylhomocysteine ratios were lower in FASD and Mthfr(+/-) livers."
"https://www.kegg.jp/entry/C00440","http://www.ihtsdo.org/SCT_206016009","5-Methyltetrahydrofolate, SAM, and SAM/S-adenosylhomocysteine ratios were lower in FASD and Mthfr(+/-) livers."
"https://www.kegg.jp/entry/C00440","http://www.ihtsdo.org/SCT_36558000","5-Methyltetrahydrofolate, SAM, and SAM/S-adenosylhomocysteine ratios were lower in FASD and Mthfr(+/-) livers."
"https://www.kegg.jp/entry/C00440","http://www.ihtsdo.org/SCT_609437000","5-Methyltetrahydrofolate, SAM, and SAM/S-adenosylhomocysteine ratios were lower in FASD and Mthfr(+/-) livers."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_154469006","Transcriptional regulation of the albumin gene depends on the removal of histone methylation marks by the FAD-dependent monoamine oxidase lysine-specific demethylase 1 in HepG2 human hepatocarcinoma cells"
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_187769009","Transcriptional regulation of the albumin gene depends on the removal of histone methylation marks by the FAD-dependent monoamine oxidase lysine-specific demethylase 1 in HepG2 human hepatocarcinoma cells"
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_269547001","Transcriptional regulation of the albumin gene depends on the removal of histone methylation marks by the FAD-dependent monoamine oxidase lysine-specific demethylase 1 in HepG2 human hepatocarcinoma cells"
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_25370001","Transcriptional regulation of the albumin gene depends on the removal of histone methylation marks by the FAD-dependent monoamine oxidase lysine-specific demethylase 1 in HepG2 human hepatocarcinoma cells"
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_109841003","Transcriptional regulation of the albumin gene depends on the removal of histone methylation marks by the FAD-dependent monoamine oxidase lysine-specific demethylase 1 in HepG2 human hepatocarcinoma cells"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_129453003","Vitamin D3 and beta-carotene deficiency is associated with risk of esophageal squamous cell carcinoma - results of a case-control study in China"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_246199000","Vitamin D3 and beta-carotene deficiency is associated with risk of esophageal squamous cell carcinoma - results of a case-control study in China"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_260372006","Vitamin D3 and beta-carotene deficiency is associated with risk of esophageal squamous cell carcinoma - results of a case-control study in China"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_154722002","Vitamin D3 and beta-carotene deficiency is associated with risk of esophageal squamous cell carcinoma - results of a case-control study in China"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_154730001","Vitamin D3 and beta-carotene deficiency is associated with risk of esophageal squamous cell carcinoma - results of a case-control study in China"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_190595009","Vitamin D3 and beta-carotene deficiency is associated with risk of esophageal squamous cell carcinoma - results of a case-control study in China"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_190608007","Vitamin D3 and beta-carotene deficiency is associated with risk of esophageal squamous cell carcinoma - results of a case-control study in China"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_190678008","Vitamin D3 and beta-carotene deficiency is associated with risk of esophageal squamous cell carcinoma - results of a case-control study in China"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_238106006","Vitamin D3 and beta-carotene deficiency is associated with risk of esophageal squamous cell carcinoma - results of a case-control study in China"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_248325000","Vitamin D3 and beta-carotene deficiency is associated with risk of esophageal squamous cell carcinoma - results of a case-control study in China"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_2492009","Vitamin D3 and beta-carotene deficiency is associated with risk of esophageal squamous cell carcinoma - results of a case-control study in China"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_267409003","Vitamin D3 and beta-carotene deficiency is associated with risk of esophageal squamous cell carcinoma - results of a case-control study in China"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_267495004","Vitamin D3 and beta-carotene deficiency is associated with risk of esophageal squamous cell carcinoma - results of a case-control study in China"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_302868002","Vitamin D3 and beta-carotene deficiency is associated with risk of esophageal squamous cell carcinoma - results of a case-control study in China"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_47563007","Vitamin D3 and beta-carotene deficiency is associated with risk of esophageal squamous cell carcinoma - results of a case-control study in China"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_65404009","Vitamin D3 and beta-carotene deficiency is associated with risk of esophageal squamous cell carcinoma - results of a case-control study in China"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_70241007","Vitamin D3 and beta-carotene deficiency is associated with risk of esophageal squamous cell carcinoma - results of a case-control study in China"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_276804009","Vitamin D3 and beta-carotene deficiency is associated with risk of esophageal squamous cell carcinoma - results of a case-control study in China"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_235956004","Leucine supplementation had effects that were intermediate between HP and AP with regard to body composition, liver TG content, insulin sensitivity, REE and feed energy efficiency, and similar effects as HP on SM protein synthesis."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_68072000","Leucine supplementation had effects that were intermediate between HP and AP with regard to body composition, liver TG content, insulin sensitivity, REE and feed energy efficiency, and similar effects as HP on SM protein synthesis."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_62047007","Leucine supplementation had effects that were intermediate between HP and AP with regard to body composition, liver TG content, insulin sensitivity, REE and feed energy efficiency, and similar effects as HP on SM protein synthesis."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_277163006","Leucine supplementation had effects that were intermediate between HP and AP with regard to body composition, liver TG content, insulin sensitivity, REE and feed energy efficiency, and similar effects as HP on SM protein synthesis."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_10200004","Leucine supplementation had effects that were intermediate between HP and AP with regard to body composition, liver TG content, insulin sensitivity, REE and feed energy efficiency, and similar effects as HP on SM protein synthesis."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_155807008","Leucine supplementation had effects that were intermediate between HP and AP with regard to body composition, liver TG content, insulin sensitivity, REE and feed energy efficiency, and similar effects as HP on SM protein synthesis."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_155817003","Leucine supplementation had effects that were intermediate between HP and AP with regard to body composition, liver TG content, insulin sensitivity, REE and feed energy efficiency, and similar effects as HP on SM protein synthesis."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_155822003","Leucine supplementation had effects that were intermediate between HP and AP with regard to body composition, liver TG content, insulin sensitivity, REE and feed energy efficiency, and similar effects as HP on SM protein synthesis."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_197375001","Leucine supplementation had effects that were intermediate between HP and AP with regard to body composition, liver TG content, insulin sensitivity, REE and feed energy efficiency, and similar effects as HP on SM protein synthesis."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_197551000","Leucine supplementation had effects that were intermediate between HP and AP with regard to body composition, liver TG content, insulin sensitivity, REE and feed energy efficiency, and similar effects as HP on SM protein synthesis."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_235856003","Leucine supplementation had effects that were intermediate between HP and AP with regard to body composition, liver TG content, insulin sensitivity, REE and feed energy efficiency, and similar effects as HP on SM protein synthesis."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_266535008","Leucine supplementation had effects that were intermediate between HP and AP with regard to body composition, liver TG content, insulin sensitivity, REE and feed energy efficiency, and similar effects as HP on SM protein synthesis."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_62857009","Leucine supplementation had effects that were intermediate between HP and AP with regard to body composition, liver TG content, insulin sensitivity, REE and feed energy efficiency, and similar effects as HP on SM protein synthesis."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_412238008","Leucine supplementation had effects that were intermediate between HP and AP with regard to body composition, liver TG content, insulin sensitivity, REE and feed energy efficiency, and similar effects as HP on SM protein synthesis."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_88566002","Leucine supplementation had effects that were intermediate between HP and AP with regard to body composition, liver TG content, insulin sensitivity, REE and feed energy efficiency, and similar effects as HP on SM protein synthesis."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_147016002","Homocysteine and serotonin: association with postpartum depression"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_154889000","Homocysteine and serotonin: association with postpartum depression"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_191740008","Homocysteine and serotonin: association with postpartum depression"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_192475007","Homocysteine and serotonin: association with postpartum depression"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_268753005","Homocysteine and serotonin: association with postpartum depression"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_58703003","Homocysteine and serotonin: association with postpartum depression"
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_253098009","Folic acid (isolated or in combination with other vitamins and minerals) reduces the total risk for neural tube defects by 72%."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_312514006","Pectin slightly decreased iron uptake (p = NS)."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_34638006","Pectin slightly decreased iron uptake (p = NS)."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_54336006","Pectin slightly decreased iron uptake (p = NS)."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_205555008","Pectin slightly decreased iron uptake (p = NS)."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_239058007","Pectin slightly decreased iron uptake (p = NS)."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_254127001","Pectin slightly decreased iron uptake (p = NS)."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_258699004","Pectin slightly decreased iron uptake (p = NS)."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_359766000","Pectin slightly decreased iron uptake (p = NS)."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_154634001","Background: Vitamin D3 and its analogues have recently been shown to enhance the anti-tumour effects of 5- Fluorouracil (5-FU) both in vitro and in xenograft mouse model of colon cancer."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_154645003","Background: Vitamin D3 and its analogues have recently been shown to enhance the anti-tumour effects of 5- Fluorouracil (5-FU) both in vitro and in xenograft mouse model of colon cancer."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_154646002","Background: Vitamin D3 and its analogues have recently been shown to enhance the anti-tumour effects of 5- Fluorouracil (5-FU) both in vitro and in xenograft mouse model of colon cancer."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_190230000","Background: Vitamin D3 and its analogues have recently been shown to enhance the anti-tumour effects of 5- Fluorouracil (5-FU) both in vitro and in xenograft mouse model of colon cancer."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_187597000","Background: Vitamin D3 and its analogues have recently been shown to enhance the anti-tumour effects of 5- Fluorouracil (5-FU) both in vitro and in xenograft mouse model of colon cancer."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_108369006","Background: Vitamin D3 and its analogues have recently been shown to enhance the anti-tumour effects of 5- Fluorouracil (5-FU) both in vitro and in xenograft mouse model of colon cancer."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_189542002","Background: Vitamin D3 and its analogues have recently been shown to enhance the anti-tumour effects of 5- Fluorouracil (5-FU) both in vitro and in xenograft mouse model of colon cancer."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_86251006","Background: Vitamin D3 and its analogues have recently been shown to enhance the anti-tumour effects of 5- Fluorouracil (5-FU) both in vitro and in xenograft mouse model of colon cancer."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_154463007","Background: Vitamin D3 and its analogues have recently been shown to enhance the anti-tumour effects of 5- Fluorouracil (5-FU) both in vitro and in xenograft mouse model of colon cancer."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_187759003","Background: Vitamin D3 and its analogues have recently been shown to enhance the anti-tumour effects of 5- Fluorouracil (5-FU) both in vitro and in xenograft mouse model of colon cancer."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_269461008","Background: Vitamin D3 and its analogues have recently been shown to enhance the anti-tumour effects of 5- Fluorouracil (5-FU) both in vitro and in xenograft mouse model of colon cancer."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_269542007","Background: Vitamin D3 and its analogues have recently been shown to enhance the anti-tumour effects of 5- Fluorouracil (5-FU) both in vitro and in xenograft mouse model of colon cancer."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_93761005","Background: Vitamin D3 and its analogues have recently been shown to enhance the anti-tumour effects of 5- Fluorouracil (5-FU) both in vitro and in xenograft mouse model of colon cancer."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_363406005","Background: Vitamin D3 and its analogues have recently been shown to enhance the anti-tumour effects of 5- Fluorouracil (5-FU) both in vitro and in xenograft mouse model of colon cancer."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_154454005","Background: Vitamin D3 and its analogues have recently been shown to enhance the anti-tumour effects of 5- Fluorouracil (5-FU) both in vitro and in xenograft mouse model of colon cancer."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_269533000","Background: Vitamin D3 and its analogues have recently been shown to enhance the anti-tumour effects of 5- Fluorouracil (5-FU) both in vitro and in xenograft mouse model of colon cancer."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_154463007","Vitamin D3 enhances the tumouricidal effects of 5-Fluorouracil through multipathway mechanisms in azoxymethane rat model of colon cancer"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_187759003","Vitamin D3 enhances the tumouricidal effects of 5-Fluorouracil through multipathway mechanisms in azoxymethane rat model of colon cancer"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_269461008","Vitamin D3 enhances the tumouricidal effects of 5-Fluorouracil through multipathway mechanisms in azoxymethane rat model of colon cancer"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_269542007","Vitamin D3 enhances the tumouricidal effects of 5-Fluorouracil through multipathway mechanisms in azoxymethane rat model of colon cancer"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_93761005","Vitamin D3 enhances the tumouricidal effects of 5-Fluorouracil through multipathway mechanisms in azoxymethane rat model of colon cancer"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_363406005","Vitamin D3 enhances the tumouricidal effects of 5-Fluorouracil through multipathway mechanisms in azoxymethane rat model of colon cancer"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_154454005","Vitamin D3 enhances the tumouricidal effects of 5-Fluorouracil through multipathway mechanisms in azoxymethane rat model of colon cancer"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_269533000","Vitamin D3 enhances the tumouricidal effects of 5-Fluorouracil through multipathway mechanisms in azoxymethane rat model of colon cancer"
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_225655006","Glycine/taurine-conjugated primary BAs increased over time in ICU (P &lt; 0.01), similarly for the two groups."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_396275006","Glycine/taurine-conjugated primary BAs increased over time in ICU (P &lt; 0.01), similarly for the two groups."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_156486003","Glycine/taurine-conjugated primary BAs increased over time in ICU (P &lt; 0.01), similarly for the two groups."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_156496007","Glycine/taurine-conjugated primary BAs increased over time in ICU (P &lt; 0.01), similarly for the two groups."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_201818008","Glycine/taurine-conjugated primary BAs increased over time in ICU (P &lt; 0.01), similarly for the two groups."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_201886002","Glycine/taurine-conjugated primary BAs increased over time in ICU (P &lt; 0.01), similarly for the two groups."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_201917002","Glycine/taurine-conjugated primary BAs increased over time in ICU (P &lt; 0.01), similarly for the two groups."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_224729007","Glycine/taurine-conjugated primary BAs increased over time in ICU (P &lt; 0.01), similarly for the two groups."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_226586002","Glycine/taurine-conjugated primary BAs increased over time in ICU (P &lt; 0.01), similarly for the two groups."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_227588009","Glycine/taurine-conjugated primary BAs increased over time in ICU (P &lt; 0.01), similarly for the two groups."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_267888004","Glycine/taurine-conjugated primary BAs increased over time in ICU (P &lt; 0.01), similarly for the two groups."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_80843008","Glycine/taurine-conjugated primary BAs increased over time in ICU (P &lt; 0.01), similarly for the two groups."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_201887006","Glycine/taurine-conjugated primary BAs increased over time in ICU (P &lt; 0.01), similarly for the two groups."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_267893001","Glycine/taurine-conjugated primary BAs increased over time in ICU (P &lt; 0.01), similarly for the two groups."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_253098009","Folic acid taken in early pregnancy can prevent neural tube defects."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_253098009","Folic acid fortification prevents neural tube defects and may also reduce cancer risks"
"https://www.kegg.jp/entry/C00116","http://www.ihtsdo.org/SCT_10200004","Glycerol is an important metabolite for the control of lipid accumulation in white adipose tissue (WAT) and liver."
"https://www.kegg.jp/entry/C00116","http://www.ihtsdo.org/SCT_155807008","Glycerol is an important metabolite for the control of lipid accumulation in white adipose tissue (WAT) and liver."
"https://www.kegg.jp/entry/C00116","http://www.ihtsdo.org/SCT_155817003","Glycerol is an important metabolite for the control of lipid accumulation in white adipose tissue (WAT) and liver."
"https://www.kegg.jp/entry/C00116","http://www.ihtsdo.org/SCT_155822003","Glycerol is an important metabolite for the control of lipid accumulation in white adipose tissue (WAT) and liver."
"https://www.kegg.jp/entry/C00116","http://www.ihtsdo.org/SCT_197375001","Glycerol is an important metabolite for the control of lipid accumulation in white adipose tissue (WAT) and liver."
"https://www.kegg.jp/entry/C00116","http://www.ihtsdo.org/SCT_197551000","Glycerol is an important metabolite for the control of lipid accumulation in white adipose tissue (WAT) and liver."
"https://www.kegg.jp/entry/C00116","http://www.ihtsdo.org/SCT_235856003","Glycerol is an important metabolite for the control of lipid accumulation in white adipose tissue (WAT) and liver."
"https://www.kegg.jp/entry/C00116","http://www.ihtsdo.org/SCT_266535008","Glycerol is an important metabolite for the control of lipid accumulation in white adipose tissue (WAT) and liver."
"https://www.kegg.jp/entry/C00116","http://www.ihtsdo.org/SCT_62857009","Glycerol is an important metabolite for the control of lipid accumulation in white adipose tissue (WAT) and liver."
"https://www.kegg.jp/entry/C00116","http://www.ihtsdo.org/SCT_412238008","Glycerol is an important metabolite for the control of lipid accumulation in white adipose tissue (WAT) and liver."
"https://www.kegg.jp/entry/C00116","http://www.ihtsdo.org/SCT_88566002","Glycerol is an important metabolite for the control of lipid accumulation in white adipose tissue (WAT) and liver."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_127072000","High-Esterified Pectin Reverses Metabolic Malprogramming, Improving Sensitivity to Adipostatic/Adipokine Hormones"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_157754004","High-Esterified Pectin Reverses Metabolic Malprogramming, Improving Sensitivity to Adipostatic/Adipokine Hormones"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_157758001","High-Esterified Pectin Reverses Metabolic Malprogramming, Improving Sensitivity to Adipostatic/Adipokine Hormones"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_212998004","High-Esterified Pectin Reverses Metabolic Malprogramming, Improving Sensitivity to Adipostatic/Adipokine Hormones"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_212999007","High-Esterified Pectin Reverses Metabolic Malprogramming, Improving Sensitivity to Adipostatic/Adipokine Hormones"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_21957007","High-Esterified Pectin Reverses Metabolic Malprogramming, Improving Sensitivity to Adipostatic/Adipokine Hormones"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_257550005","High-Esterified Pectin Reverses Metabolic Malprogramming, Improving Sensitivity to Adipostatic/Adipokine Hormones"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_269432007","High-Esterified Pectin Reverses Metabolic Malprogramming, Improving Sensitivity to Adipostatic/Adipokine Hormones"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_274211000","High-Esterified Pectin Reverses Metabolic Malprogramming, Improving Sensitivity to Adipostatic/Adipokine Hormones"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_282092005","High-Esterified Pectin Reverses Metabolic Malprogramming, Improving Sensitivity to Adipostatic/Adipokine Hormones"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_418168000","High-Esterified Pectin Reverses Metabolic Malprogramming, Improving Sensitivity to Adipostatic/Adipokine Hormones"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_418634005","High-Esterified Pectin Reverses Metabolic Malprogramming, Improving Sensitivity to Adipostatic/Adipokine Hormones"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_91232002","High-Esterified Pectin Reverses Metabolic Malprogramming, Improving Sensitivity to Adipostatic/Adipokine Hormones"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_421961002","High-Esterified Pectin Reverses Metabolic Malprogramming, Improving Sensitivity to Adipostatic/Adipokine Hormones"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_106190000","High-Esterified Pectin Reverses Metabolic Malprogramming, Improving Sensitivity to Adipostatic/Adipokine Hormones"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_269284003","High-Esterified Pectin Reverses Metabolic Malprogramming, Improving Sensitivity to Adipostatic/Adipokine Hormones"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_418925002","High-Esterified Pectin Reverses Metabolic Malprogramming, Improving Sensitivity to Adipostatic/Adipokine Hormones"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_421668005","High-Esterified Pectin Reverses Metabolic Malprogramming, Improving Sensitivity to Adipostatic/Adipokine Hormones"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_35209006","High-Esterified Pectin Reverses Metabolic Malprogramming, Improving Sensitivity to Adipostatic/Adipokine Hormones"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_367351005","High-Esterified Pectin Reverses Metabolic Malprogramming, Improving Sensitivity to Adipostatic/Adipokine Hormones"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_14788002","High-Esterified Pectin Reverses Metabolic Malprogramming, Improving Sensitivity to Adipostatic/Adipokine Hormones"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_365705006","High-Esterified Pectin Reverses Metabolic Malprogramming, Improving Sensitivity to Adipostatic/Adipokine Hormones"
"https://www.kegg.jp/entry/C00068","http://www.ihtsdo.org/SCT_386136009","The level of NTKZ and %TPP were statistically different between the analyzed groups, showing the deficit of vitamin B1 in the group of moderate-to-severe active CD patients (Mean ± SD; NTKZ: 1.99 ± 0.87 vs. 1.54 ± 0.62 U/g Hb; % of TPP: 0.15 ± 0.78 vs. 54.90 ± 38.80)."
"https://www.kegg.jp/entry/C00068","http://www.ihtsdo.org/SCT_87074006","The level of NTKZ and %TPP were statistically different between the analyzed groups, showing the deficit of vitamin B1 in the group of moderate-to-severe active CD patients (Mean ± SD; NTKZ: 1.99 ± 0.87 vs. 1.54 ± 0.62 U/g Hb; % of TPP: 0.15 ± 0.78 vs. 54.90 ± 38.80)."
"https://www.kegg.jp/entry/C00068","http://www.ihtsdo.org/SCT_154722002","The level of NTKZ and %TPP were statistically different between the analyzed groups, showing the deficit of vitamin B1 in the group of moderate-to-severe active CD patients (Mean ± SD; NTKZ: 1.99 ± 0.87 vs. 1.54 ± 0.62 U/g Hb; % of TPP: 0.15 ± 0.78 vs. 54.90 ± 38.80)."
"https://www.kegg.jp/entry/C00068","http://www.ihtsdo.org/SCT_154730001","The level of NTKZ and %TPP were statistically different between the analyzed groups, showing the deficit of vitamin B1 in the group of moderate-to-severe active CD patients (Mean ± SD; NTKZ: 1.99 ± 0.87 vs. 1.54 ± 0.62 U/g Hb; % of TPP: 0.15 ± 0.78 vs. 54.90 ± 38.80)."
"https://www.kegg.jp/entry/C00068","http://www.ihtsdo.org/SCT_190595009","The level of NTKZ and %TPP were statistically different between the analyzed groups, showing the deficit of vitamin B1 in the group of moderate-to-severe active CD patients (Mean ± SD; NTKZ: 1.99 ± 0.87 vs. 1.54 ± 0.62 U/g Hb; % of TPP: 0.15 ± 0.78 vs. 54.90 ± 38.80)."
"https://www.kegg.jp/entry/C00068","http://www.ihtsdo.org/SCT_190608007","The level of NTKZ and %TPP were statistically different between the analyzed groups, showing the deficit of vitamin B1 in the group of moderate-to-severe active CD patients (Mean ± SD; NTKZ: 1.99 ± 0.87 vs. 1.54 ± 0.62 U/g Hb; % of TPP: 0.15 ± 0.78 vs. 54.90 ± 38.80)."
"https://www.kegg.jp/entry/C00068","http://www.ihtsdo.org/SCT_190678008","The level of NTKZ and %TPP were statistically different between the analyzed groups, showing the deficit of vitamin B1 in the group of moderate-to-severe active CD patients (Mean ± SD; NTKZ: 1.99 ± 0.87 vs. 1.54 ± 0.62 U/g Hb; % of TPP: 0.15 ± 0.78 vs. 54.90 ± 38.80)."
"https://www.kegg.jp/entry/C00068","http://www.ihtsdo.org/SCT_238106006","The level of NTKZ and %TPP were statistically different between the analyzed groups, showing the deficit of vitamin B1 in the group of moderate-to-severe active CD patients (Mean ± SD; NTKZ: 1.99 ± 0.87 vs. 1.54 ± 0.62 U/g Hb; % of TPP: 0.15 ± 0.78 vs. 54.90 ± 38.80)."
"https://www.kegg.jp/entry/C00068","http://www.ihtsdo.org/SCT_248325000","The level of NTKZ and %TPP were statistically different between the analyzed groups, showing the deficit of vitamin B1 in the group of moderate-to-severe active CD patients (Mean ± SD; NTKZ: 1.99 ± 0.87 vs. 1.54 ± 0.62 U/g Hb; % of TPP: 0.15 ± 0.78 vs. 54.90 ± 38.80)."
"https://www.kegg.jp/entry/C00068","http://www.ihtsdo.org/SCT_2492009","The level of NTKZ and %TPP were statistically different between the analyzed groups, showing the deficit of vitamin B1 in the group of moderate-to-severe active CD patients (Mean ± SD; NTKZ: 1.99 ± 0.87 vs. 1.54 ± 0.62 U/g Hb; % of TPP: 0.15 ± 0.78 vs. 54.90 ± 38.80)."
"https://www.kegg.jp/entry/C00068","http://www.ihtsdo.org/SCT_267409003","The level of NTKZ and %TPP were statistically different between the analyzed groups, showing the deficit of vitamin B1 in the group of moderate-to-severe active CD patients (Mean ± SD; NTKZ: 1.99 ± 0.87 vs. 1.54 ± 0.62 U/g Hb; % of TPP: 0.15 ± 0.78 vs. 54.90 ± 38.80)."
"https://www.kegg.jp/entry/C00068","http://www.ihtsdo.org/SCT_267495004","The level of NTKZ and %TPP were statistically different between the analyzed groups, showing the deficit of vitamin B1 in the group of moderate-to-severe active CD patients (Mean ± SD; NTKZ: 1.99 ± 0.87 vs. 1.54 ± 0.62 U/g Hb; % of TPP: 0.15 ± 0.78 vs. 54.90 ± 38.80)."
"https://www.kegg.jp/entry/C00068","http://www.ihtsdo.org/SCT_302868002","The level of NTKZ and %TPP were statistically different between the analyzed groups, showing the deficit of vitamin B1 in the group of moderate-to-severe active CD patients (Mean ± SD; NTKZ: 1.99 ± 0.87 vs. 1.54 ± 0.62 U/g Hb; % of TPP: 0.15 ± 0.78 vs. 54.90 ± 38.80)."
"https://www.kegg.jp/entry/C00068","http://www.ihtsdo.org/SCT_47563007","The level of NTKZ and %TPP were statistically different between the analyzed groups, showing the deficit of vitamin B1 in the group of moderate-to-severe active CD patients (Mean ± SD; NTKZ: 1.99 ± 0.87 vs. 1.54 ± 0.62 U/g Hb; % of TPP: 0.15 ± 0.78 vs. 54.90 ± 38.80)."
"https://www.kegg.jp/entry/C00068","http://www.ihtsdo.org/SCT_65404009","The level of NTKZ and %TPP were statistically different between the analyzed groups, showing the deficit of vitamin B1 in the group of moderate-to-severe active CD patients (Mean ± SD; NTKZ: 1.99 ± 0.87 vs. 1.54 ± 0.62 U/g Hb; % of TPP: 0.15 ± 0.78 vs. 54.90 ± 38.80)."
"https://www.kegg.jp/entry/C00068","http://www.ihtsdo.org/SCT_70241007","The level of NTKZ and %TPP were statistically different between the analyzed groups, showing the deficit of vitamin B1 in the group of moderate-to-severe active CD patients (Mean ± SD; NTKZ: 1.99 ± 0.87 vs. 1.54 ± 0.62 U/g Hb; % of TPP: 0.15 ± 0.78 vs. 54.90 ± 38.80)."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_422504002","Glycine intake was significantly associated with an increased risk of mortality from total and ischemic stroke in men without history of hypertension at baseline; the HRs (95% CIs) for the highest vs. lowest tertile were 1.60 (0.97, 2.51; P-trend: 0.03) and 1.88 (1.01, 3.52; P-trend: 0.02), respectively."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_68116008","Glycine intake was significantly associated with an increased risk of mortality from total and ischemic stroke in men without history of hypertension at baseline; the HRs (95% CIs) for the highest vs. lowest tertile were 1.60 (0.97, 2.51; P-trend: 0.03) and 1.88 (1.01, 3.52; P-trend: 0.02), respectively."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_702422004","Glycine intake was significantly associated with an increased risk of mortality from total and ischemic stroke in men without history of hypertension at baseline; the HRs (95% CIs) for the highest vs. lowest tertile were 1.60 (0.97, 2.51; P-trend: 0.03) and 1.88 (1.01, 3.52; P-trend: 0.02), respectively."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_59455009","Thiamine responsive acute life threatening metabolic acidosis in exclusively breast-fed infants"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_155648008","Sucrose and starch intake contribute to reduced alveolar bone height in a rodent model of naturally occurring periodontitis"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_266491004","Sucrose and starch intake contribute to reduced alveolar bone height in a rodent model of naturally occurring periodontitis"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_41565005","Sucrose and starch intake contribute to reduced alveolar bone height in a rodent model of naturally occurring periodontitis"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_129453003","Dysregulation of PP2A-Akt interaction contributes to Sucrose non-fermenting related kinase (SNRK) deficiency induced insulin resistance in adipose tissue"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_246199000","Dysregulation of PP2A-Akt interaction contributes to Sucrose non-fermenting related kinase (SNRK) deficiency induced insulin resistance in adipose tissue"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_260372006","Dysregulation of PP2A-Akt interaction contributes to Sucrose non-fermenting related kinase (SNRK) deficiency induced insulin resistance in adipose tissue"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_154722002","Dysregulation of PP2A-Akt interaction contributes to Sucrose non-fermenting related kinase (SNRK) deficiency induced insulin resistance in adipose tissue"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_154730001","Dysregulation of PP2A-Akt interaction contributes to Sucrose non-fermenting related kinase (SNRK) deficiency induced insulin resistance in adipose tissue"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_190595009","Dysregulation of PP2A-Akt interaction contributes to Sucrose non-fermenting related kinase (SNRK) deficiency induced insulin resistance in adipose tissue"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_190608007","Dysregulation of PP2A-Akt interaction contributes to Sucrose non-fermenting related kinase (SNRK) deficiency induced insulin resistance in adipose tissue"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_190678008","Dysregulation of PP2A-Akt interaction contributes to Sucrose non-fermenting related kinase (SNRK) deficiency induced insulin resistance in adipose tissue"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_238106006","Dysregulation of PP2A-Akt interaction contributes to Sucrose non-fermenting related kinase (SNRK) deficiency induced insulin resistance in adipose tissue"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_248325000","Dysregulation of PP2A-Akt interaction contributes to Sucrose non-fermenting related kinase (SNRK) deficiency induced insulin resistance in adipose tissue"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_2492009","Dysregulation of PP2A-Akt interaction contributes to Sucrose non-fermenting related kinase (SNRK) deficiency induced insulin resistance in adipose tissue"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_267409003","Dysregulation of PP2A-Akt interaction contributes to Sucrose non-fermenting related kinase (SNRK) deficiency induced insulin resistance in adipose tissue"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_267495004","Dysregulation of PP2A-Akt interaction contributes to Sucrose non-fermenting related kinase (SNRK) deficiency induced insulin resistance in adipose tissue"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_302868002","Dysregulation of PP2A-Akt interaction contributes to Sucrose non-fermenting related kinase (SNRK) deficiency induced insulin resistance in adipose tissue"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_47563007","Dysregulation of PP2A-Akt interaction contributes to Sucrose non-fermenting related kinase (SNRK) deficiency induced insulin resistance in adipose tissue"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_65404009","Dysregulation of PP2A-Akt interaction contributes to Sucrose non-fermenting related kinase (SNRK) deficiency induced insulin resistance in adipose tissue"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_70241007","Dysregulation of PP2A-Akt interaction contributes to Sucrose non-fermenting related kinase (SNRK) deficiency induced insulin resistance in adipose tissue"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_48606007","Dysregulation of PP2A-Akt interaction contributes to Sucrose non-fermenting related kinase (SNRK) deficiency induced insulin resistance in adipose tissue"
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_127072000","Biotin interferences have been reported for high-sensitive troponin T (hsTnT) and thyroid-stimulating hormone (TSH) assays."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_157754004","Biotin interferences have been reported for high-sensitive troponin T (hsTnT) and thyroid-stimulating hormone (TSH) assays."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_157758001","Biotin interferences have been reported for high-sensitive troponin T (hsTnT) and thyroid-stimulating hormone (TSH) assays."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_212998004","Biotin interferences have been reported for high-sensitive troponin T (hsTnT) and thyroid-stimulating hormone (TSH) assays."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_212999007","Biotin interferences have been reported for high-sensitive troponin T (hsTnT) and thyroid-stimulating hormone (TSH) assays."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_21957007","Biotin interferences have been reported for high-sensitive troponin T (hsTnT) and thyroid-stimulating hormone (TSH) assays."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_257550005","Biotin interferences have been reported for high-sensitive troponin T (hsTnT) and thyroid-stimulating hormone (TSH) assays."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_269432007","Biotin interferences have been reported for high-sensitive troponin T (hsTnT) and thyroid-stimulating hormone (TSH) assays."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_274211000","Biotin interferences have been reported for high-sensitive troponin T (hsTnT) and thyroid-stimulating hormone (TSH) assays."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_282092005","Biotin interferences have been reported for high-sensitive troponin T (hsTnT) and thyroid-stimulating hormone (TSH) assays."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_418168000","Biotin interferences have been reported for high-sensitive troponin T (hsTnT) and thyroid-stimulating hormone (TSH) assays."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_418634005","Biotin interferences have been reported for high-sensitive troponin T (hsTnT) and thyroid-stimulating hormone (TSH) assays."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_91232002","Biotin interferences have been reported for high-sensitive troponin T (hsTnT) and thyroid-stimulating hormone (TSH) assays."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_421961002","Biotin interferences have been reported for high-sensitive troponin T (hsTnT) and thyroid-stimulating hormone (TSH) assays."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_106190000","Biotin interferences have been reported for high-sensitive troponin T (hsTnT) and thyroid-stimulating hormone (TSH) assays."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_269284003","Biotin interferences have been reported for high-sensitive troponin T (hsTnT) and thyroid-stimulating hormone (TSH) assays."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_418925002","Biotin interferences have been reported for high-sensitive troponin T (hsTnT) and thyroid-stimulating hormone (TSH) assays."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_421668005","Biotin interferences have been reported for high-sensitive troponin T (hsTnT) and thyroid-stimulating hormone (TSH) assays."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_83185005","Biotin interferences have been reported for high-sensitive troponin T (hsTnT) and thyroid-stimulating hormone (TSH) assays."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_75934005","Background/objectives: Sucrose-sweetened soft drinks (SSSDs) are associated with the development of metabolic disorders."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_154733004","Background/objectives: Sucrose-sweetened soft drinks (SSSDs) are associated with the development of metabolic disorders."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_190961002","Background/objectives: Sucrose-sweetened soft drinks (SSSDs) are associated with the development of metabolic disorders."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_30390004","Background/objectives: Sucrose-sweetened soft drinks (SSSDs) are associated with the development of metabolic disorders."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_267456000","Background/objectives: Sucrose-sweetened soft drinks (SSSDs) are associated with the development of metabolic disorders."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_124886009","Vitamin D3 was protective against vitamin D deficiency-induced cholesterol increase by maintaining the transcriptional activity of VDR and Insig-2 expression."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_154728003","Vitamin D3 was protective against vitamin D deficiency-induced cholesterol increase by maintaining the transcriptional activity of VDR and Insig-2 expression."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_190639009","Vitamin D3 was protective against vitamin D deficiency-induced cholesterol increase by maintaining the transcriptional activity of VDR and Insig-2 expression."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_190649007","Vitamin D3 was protective against vitamin D deficiency-induced cholesterol increase by maintaining the transcriptional activity of VDR and Insig-2 expression."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_34713006","Vitamin D3 was protective against vitamin D deficiency-induced cholesterol increase by maintaining the transcriptional activity of VDR and Insig-2 expression."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_363510005","Folic acid fortification and colorectal cancer risk"
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_93854002","Folic acid fortification and colorectal cancer risk"
"https://www.kegg.jp/entry/C00253","http://www.ihtsdo.org/SCT_64572001","Nicotinic acid, also known as niacin, is the water soluble vitamin B3 used for decades for the treatment of dyslipidemic diseases."
"https://www.kegg.jp/entry/C00253","http://www.ihtsdo.org/SCT_370992007","Nicotinic acid, also known as niacin, is the water soluble vitamin B3 used for decades for the treatment of dyslipidemic diseases."
"https://www.kegg.jp/entry/C00072","http://www.ihtsdo.org/SCT_154671004","Ascorbic acid supplementation improves postprandial glycaemic control and blood pressure in individuals with type 2 diabetes: Findings of a randomized cross-over trial"
"https://www.kegg.jp/entry/C00072","http://www.ihtsdo.org/SCT_191044006","Ascorbic acid supplementation improves postprandial glycaemic control and blood pressure in individuals with type 2 diabetes: Findings of a randomized cross-over trial"
"https://www.kegg.jp/entry/C00072","http://www.ihtsdo.org/SCT_267467004","Ascorbic acid supplementation improves postprandial glycaemic control and blood pressure in individuals with type 2 diabetes: Findings of a randomized cross-over trial"
"https://www.kegg.jp/entry/C00072","http://www.ihtsdo.org/SCT_73211009","Ascorbic acid supplementation improves postprandial glycaemic control and blood pressure in individuals with type 2 diabetes: Findings of a randomized cross-over trial"
"https://www.kegg.jp/entry/C01673","http://www.ihtsdo.org/SCT_363354003","Calcitriol increases Dicer expression and modifies the microRNAs signature in SiHa cervical cancer cells"
"https://www.kegg.jp/entry/C01673","http://www.ihtsdo.org/SCT_188174005","Calcitriol increases Dicer expression and modifies the microRNAs signature in SiHa cervical cancer cells"
"https://www.kegg.jp/entry/C01673","http://www.ihtsdo.org/SCT_254885005","Calcitriol increases Dicer expression and modifies the microRNAs signature in SiHa cervical cancer cells"
"https://www.kegg.jp/entry/C01673","http://www.ihtsdo.org/SCT_93752005","Calcitriol increases Dicer expression and modifies the microRNAs signature in SiHa cervical cancer cells"
"https://www.kegg.jp/entry/C01673","http://www.ihtsdo.org/SCT_188186008","Calcitriol increases Dicer expression and modifies the microRNAs signature in SiHa cervical cancer cells"
"https://www.kegg.jp/entry/C01673","http://www.ihtsdo.org/SCT_154522004","Calcitriol increases Dicer expression and modifies the microRNAs signature in SiHa cervical cancer cells"
"https://www.kegg.jp/entry/C01673","http://www.ihtsdo.org/SCT_154525002","Calcitriol increases Dicer expression and modifies the microRNAs signature in SiHa cervical cancer cells"
"https://www.kegg.jp/entry/C01673","http://www.ihtsdo.org/SCT_269596006","Calcitriol increases Dicer expression and modifies the microRNAs signature in SiHa cervical cancer cells"
"https://www.kegg.jp/entry/C01673","http://www.ihtsdo.org/SCT_285432005","Calcitriol increases Dicer expression and modifies the microRNAs signature in SiHa cervical cancer cells"
"https://www.kegg.jp/entry/C01673","http://www.ihtsdo.org/SCT_269599004","Calcitriol increases Dicer expression and modifies the microRNAs signature in SiHa cervical cancer cells"
"https://www.kegg.jp/entry/C00864","http://www.ihtsdo.org/SCT_238128006","Pantothenic acid refeeding diminishes the liver, perinephrical fats, and plasma fats accumulated by pantothenic acid deficiency and/or ethanol consumption"
"https://www.kegg.jp/entry/C00864","http://www.ihtsdo.org/SCT_124916000","Pantothenic acid refeeding diminishes the liver, perinephrical fats, and plasma fats accumulated by pantothenic acid deficiency and/or ethanol consumption"
"https://www.kegg.jp/entry/C00864","http://www.ihtsdo.org/SCT_10200004","Pantothenic acid refeeding diminishes the liver, perinephrical fats, and plasma fats accumulated by pantothenic acid deficiency and/or ethanol consumption"
"https://www.kegg.jp/entry/C00864","http://www.ihtsdo.org/SCT_155807008","Pantothenic acid refeeding diminishes the liver, perinephrical fats, and plasma fats accumulated by pantothenic acid deficiency and/or ethanol consumption"
"https://www.kegg.jp/entry/C00864","http://www.ihtsdo.org/SCT_155817003","Pantothenic acid refeeding diminishes the liver, perinephrical fats, and plasma fats accumulated by pantothenic acid deficiency and/or ethanol consumption"
"https://www.kegg.jp/entry/C00864","http://www.ihtsdo.org/SCT_155822003","Pantothenic acid refeeding diminishes the liver, perinephrical fats, and plasma fats accumulated by pantothenic acid deficiency and/or ethanol consumption"
"https://www.kegg.jp/entry/C00864","http://www.ihtsdo.org/SCT_197375001","Pantothenic acid refeeding diminishes the liver, perinephrical fats, and plasma fats accumulated by pantothenic acid deficiency and/or ethanol consumption"
"https://www.kegg.jp/entry/C00864","http://www.ihtsdo.org/SCT_197551000","Pantothenic acid refeeding diminishes the liver, perinephrical fats, and plasma fats accumulated by pantothenic acid deficiency and/or ethanol consumption"
"https://www.kegg.jp/entry/C00864","http://www.ihtsdo.org/SCT_235856003","Pantothenic acid refeeding diminishes the liver, perinephrical fats, and plasma fats accumulated by pantothenic acid deficiency and/or ethanol consumption"
"https://www.kegg.jp/entry/C00864","http://www.ihtsdo.org/SCT_266535008","Pantothenic acid refeeding diminishes the liver, perinephrical fats, and plasma fats accumulated by pantothenic acid deficiency and/or ethanol consumption"
"https://www.kegg.jp/entry/C00864","http://www.ihtsdo.org/SCT_62857009","Pantothenic acid refeeding diminishes the liver, perinephrical fats, and plasma fats accumulated by pantothenic acid deficiency and/or ethanol consumption"
"https://www.kegg.jp/entry/C00864","http://www.ihtsdo.org/SCT_412238008","Pantothenic acid refeeding diminishes the liver, perinephrical fats, and plasma fats accumulated by pantothenic acid deficiency and/or ethanol consumption"
"https://www.kegg.jp/entry/C00864","http://www.ihtsdo.org/SCT_88566002","Pantothenic acid refeeding diminishes the liver, perinephrical fats, and plasma fats accumulated by pantothenic acid deficiency and/or ethanol consumption"
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_129453003","These findings suggest that feeding either Fe or DHA/EPA alone to adult rats with both ID and (n-3)FAD affects the DA and 5-HT pathways differently than combined repletion and exacerbates the cognitive deficits associated with combined deficiency."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_246199000","These findings suggest that feeding either Fe or DHA/EPA alone to adult rats with both ID and (n-3)FAD affects the DA and 5-HT pathways differently than combined repletion and exacerbates the cognitive deficits associated with combined deficiency."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_260372006","These findings suggest that feeding either Fe or DHA/EPA alone to adult rats with both ID and (n-3)FAD affects the DA and 5-HT pathways differently than combined repletion and exacerbates the cognitive deficits associated with combined deficiency."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_154722002","These findings suggest that feeding either Fe or DHA/EPA alone to adult rats with both ID and (n-3)FAD affects the DA and 5-HT pathways differently than combined repletion and exacerbates the cognitive deficits associated with combined deficiency."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_154730001","These findings suggest that feeding either Fe or DHA/EPA alone to adult rats with both ID and (n-3)FAD affects the DA and 5-HT pathways differently than combined repletion and exacerbates the cognitive deficits associated with combined deficiency."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_190595009","These findings suggest that feeding either Fe or DHA/EPA alone to adult rats with both ID and (n-3)FAD affects the DA and 5-HT pathways differently than combined repletion and exacerbates the cognitive deficits associated with combined deficiency."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_190608007","These findings suggest that feeding either Fe or DHA/EPA alone to adult rats with both ID and (n-3)FAD affects the DA and 5-HT pathways differently than combined repletion and exacerbates the cognitive deficits associated with combined deficiency."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_190678008","These findings suggest that feeding either Fe or DHA/EPA alone to adult rats with both ID and (n-3)FAD affects the DA and 5-HT pathways differently than combined repletion and exacerbates the cognitive deficits associated with combined deficiency."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_238106006","These findings suggest that feeding either Fe or DHA/EPA alone to adult rats with both ID and (n-3)FAD affects the DA and 5-HT pathways differently than combined repletion and exacerbates the cognitive deficits associated with combined deficiency."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_248325000","These findings suggest that feeding either Fe or DHA/EPA alone to adult rats with both ID and (n-3)FAD affects the DA and 5-HT pathways differently than combined repletion and exacerbates the cognitive deficits associated with combined deficiency."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_2492009","These findings suggest that feeding either Fe or DHA/EPA alone to adult rats with both ID and (n-3)FAD affects the DA and 5-HT pathways differently than combined repletion and exacerbates the cognitive deficits associated with combined deficiency."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_267409003","These findings suggest that feeding either Fe or DHA/EPA alone to adult rats with both ID and (n-3)FAD affects the DA and 5-HT pathways differently than combined repletion and exacerbates the cognitive deficits associated with combined deficiency."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_267495004","These findings suggest that feeding either Fe or DHA/EPA alone to adult rats with both ID and (n-3)FAD affects the DA and 5-HT pathways differently than combined repletion and exacerbates the cognitive deficits associated with combined deficiency."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_302868002","These findings suggest that feeding either Fe or DHA/EPA alone to adult rats with both ID and (n-3)FAD affects the DA and 5-HT pathways differently than combined repletion and exacerbates the cognitive deficits associated with combined deficiency."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_47563007","These findings suggest that feeding either Fe or DHA/EPA alone to adult rats with both ID and (n-3)FAD affects the DA and 5-HT pathways differently than combined repletion and exacerbates the cognitive deficits associated with combined deficiency."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_65404009","These findings suggest that feeding either Fe or DHA/EPA alone to adult rats with both ID and (n-3)FAD affects the DA and 5-HT pathways differently than combined repletion and exacerbates the cognitive deficits associated with combined deficiency."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_70241007","These findings suggest that feeding either Fe or DHA/EPA alone to adult rats with both ID and (n-3)FAD affects the DA and 5-HT pathways differently than combined repletion and exacerbates the cognitive deficits associated with combined deficiency."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_129453003","Concurrent deficiencies of iron (Fe) (ID) and (n-3) fatty acids [(n-3)FAD)] in rats can alter brain monoamine pathways and impair learning and memory."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_246199000","Concurrent deficiencies of iron (Fe) (ID) and (n-3) fatty acids [(n-3)FAD)] in rats can alter brain monoamine pathways and impair learning and memory."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_260372006","Concurrent deficiencies of iron (Fe) (ID) and (n-3) fatty acids [(n-3)FAD)] in rats can alter brain monoamine pathways and impair learning and memory."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_154722002","Concurrent deficiencies of iron (Fe) (ID) and (n-3) fatty acids [(n-3)FAD)] in rats can alter brain monoamine pathways and impair learning and memory."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_154730001","Concurrent deficiencies of iron (Fe) (ID) and (n-3) fatty acids [(n-3)FAD)] in rats can alter brain monoamine pathways and impair learning and memory."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_190595009","Concurrent deficiencies of iron (Fe) (ID) and (n-3) fatty acids [(n-3)FAD)] in rats can alter brain monoamine pathways and impair learning and memory."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_190608007","Concurrent deficiencies of iron (Fe) (ID) and (n-3) fatty acids [(n-3)FAD)] in rats can alter brain monoamine pathways and impair learning and memory."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_190678008","Concurrent deficiencies of iron (Fe) (ID) and (n-3) fatty acids [(n-3)FAD)] in rats can alter brain monoamine pathways and impair learning and memory."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_238106006","Concurrent deficiencies of iron (Fe) (ID) and (n-3) fatty acids [(n-3)FAD)] in rats can alter brain monoamine pathways and impair learning and memory."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_248325000","Concurrent deficiencies of iron (Fe) (ID) and (n-3) fatty acids [(n-3)FAD)] in rats can alter brain monoamine pathways and impair learning and memory."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_2492009","Concurrent deficiencies of iron (Fe) (ID) and (n-3) fatty acids [(n-3)FAD)] in rats can alter brain monoamine pathways and impair learning and memory."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_267409003","Concurrent deficiencies of iron (Fe) (ID) and (n-3) fatty acids [(n-3)FAD)] in rats can alter brain monoamine pathways and impair learning and memory."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_267495004","Concurrent deficiencies of iron (Fe) (ID) and (n-3) fatty acids [(n-3)FAD)] in rats can alter brain monoamine pathways and impair learning and memory."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_302868002","Concurrent deficiencies of iron (Fe) (ID) and (n-3) fatty acids [(n-3)FAD)] in rats can alter brain monoamine pathways and impair learning and memory."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_47563007","Concurrent deficiencies of iron (Fe) (ID) and (n-3) fatty acids [(n-3)FAD)] in rats can alter brain monoamine pathways and impair learning and memory."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_65404009","Concurrent deficiencies of iron (Fe) (ID) and (n-3) fatty acids [(n-3)FAD)] in rats can alter brain monoamine pathways and impair learning and memory."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_70241007","Concurrent deficiencies of iron (Fe) (ID) and (n-3) fatty acids [(n-3)FAD)] in rats can alter brain monoamine pathways and impair learning and memory."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_129453003","These results suggest that the combined deficiencies of Fe and (n-3) FA disrupt brain monoamine metabolism and produce greater deficits in reference memory than ID or (n-3)FAD alone."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_246199000","These results suggest that the combined deficiencies of Fe and (n-3) FA disrupt brain monoamine metabolism and produce greater deficits in reference memory than ID or (n-3)FAD alone."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_260372006","These results suggest that the combined deficiencies of Fe and (n-3) FA disrupt brain monoamine metabolism and produce greater deficits in reference memory than ID or (n-3)FAD alone."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_154722002","These results suggest that the combined deficiencies of Fe and (n-3) FA disrupt brain monoamine metabolism and produce greater deficits in reference memory than ID or (n-3)FAD alone."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_154730001","These results suggest that the combined deficiencies of Fe and (n-3) FA disrupt brain monoamine metabolism and produce greater deficits in reference memory than ID or (n-3)FAD alone."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_190595009","These results suggest that the combined deficiencies of Fe and (n-3) FA disrupt brain monoamine metabolism and produce greater deficits in reference memory than ID or (n-3)FAD alone."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_190608007","These results suggest that the combined deficiencies of Fe and (n-3) FA disrupt brain monoamine metabolism and produce greater deficits in reference memory than ID or (n-3)FAD alone."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_190678008","These results suggest that the combined deficiencies of Fe and (n-3) FA disrupt brain monoamine metabolism and produce greater deficits in reference memory than ID or (n-3)FAD alone."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_238106006","These results suggest that the combined deficiencies of Fe and (n-3) FA disrupt brain monoamine metabolism and produce greater deficits in reference memory than ID or (n-3)FAD alone."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_248325000","These results suggest that the combined deficiencies of Fe and (n-3) FA disrupt brain monoamine metabolism and produce greater deficits in reference memory than ID or (n-3)FAD alone."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_2492009","These results suggest that the combined deficiencies of Fe and (n-3) FA disrupt brain monoamine metabolism and produce greater deficits in reference memory than ID or (n-3)FAD alone."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_267409003","These results suggest that the combined deficiencies of Fe and (n-3) FA disrupt brain monoamine metabolism and produce greater deficits in reference memory than ID or (n-3)FAD alone."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_267495004","These results suggest that the combined deficiencies of Fe and (n-3) FA disrupt brain monoamine metabolism and produce greater deficits in reference memory than ID or (n-3)FAD alone."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_302868002","These results suggest that the combined deficiencies of Fe and (n-3) FA disrupt brain monoamine metabolism and produce greater deficits in reference memory than ID or (n-3)FAD alone."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_47563007","These results suggest that the combined deficiencies of Fe and (n-3) FA disrupt brain monoamine metabolism and produce greater deficits in reference memory than ID or (n-3)FAD alone."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_65404009","These results suggest that the combined deficiencies of Fe and (n-3) FA disrupt brain monoamine metabolism and produce greater deficits in reference memory than ID or (n-3)FAD alone."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_70241007","These results suggest that the combined deficiencies of Fe and (n-3) FA disrupt brain monoamine metabolism and produce greater deficits in reference memory than ID or (n-3)FAD alone."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_129453003","Deficiencies of iron (Fe) (ID) and (n-3) fatty acids (FA) [(n-3)FAD] may impair brain development and function through shared mechanisms."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_246199000","Deficiencies of iron (Fe) (ID) and (n-3) fatty acids (FA) [(n-3)FAD] may impair brain development and function through shared mechanisms."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_260372006","Deficiencies of iron (Fe) (ID) and (n-3) fatty acids (FA) [(n-3)FAD] may impair brain development and function through shared mechanisms."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_154722002","Deficiencies of iron (Fe) (ID) and (n-3) fatty acids (FA) [(n-3)FAD] may impair brain development and function through shared mechanisms."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_154730001","Deficiencies of iron (Fe) (ID) and (n-3) fatty acids (FA) [(n-3)FAD] may impair brain development and function through shared mechanisms."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_190595009","Deficiencies of iron (Fe) (ID) and (n-3) fatty acids (FA) [(n-3)FAD] may impair brain development and function through shared mechanisms."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_190608007","Deficiencies of iron (Fe) (ID) and (n-3) fatty acids (FA) [(n-3)FAD] may impair brain development and function through shared mechanisms."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_190678008","Deficiencies of iron (Fe) (ID) and (n-3) fatty acids (FA) [(n-3)FAD] may impair brain development and function through shared mechanisms."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_238106006","Deficiencies of iron (Fe) (ID) and (n-3) fatty acids (FA) [(n-3)FAD] may impair brain development and function through shared mechanisms."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_248325000","Deficiencies of iron (Fe) (ID) and (n-3) fatty acids (FA) [(n-3)FAD] may impair brain development and function through shared mechanisms."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_2492009","Deficiencies of iron (Fe) (ID) and (n-3) fatty acids (FA) [(n-3)FAD] may impair brain development and function through shared mechanisms."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_267409003","Deficiencies of iron (Fe) (ID) and (n-3) fatty acids (FA) [(n-3)FAD] may impair brain development and function through shared mechanisms."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_267495004","Deficiencies of iron (Fe) (ID) and (n-3) fatty acids (FA) [(n-3)FAD] may impair brain development and function through shared mechanisms."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_302868002","Deficiencies of iron (Fe) (ID) and (n-3) fatty acids (FA) [(n-3)FAD] may impair brain development and function through shared mechanisms."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_47563007","Deficiencies of iron (Fe) (ID) and (n-3) fatty acids (FA) [(n-3)FAD] may impair brain development and function through shared mechanisms."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_65404009","Deficiencies of iron (Fe) (ID) and (n-3) fatty acids (FA) [(n-3)FAD] may impair brain development and function through shared mechanisms."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_70241007","Deficiencies of iron (Fe) (ID) and (n-3) fatty acids (FA) [(n-3)FAD] may impair brain development and function through shared mechanisms."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_129453003","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_246199000","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_260372006","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_154722002","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_154730001","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_190595009","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_190608007","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_190678008","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_238106006","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_248325000","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_2492009","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_267409003","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_267495004","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_302868002","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_47563007","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_65404009","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_70241007","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_154432008","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_154433003","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_154577008","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_187597000","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_188475001","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_188482002","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_190150006","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_269513004","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_269623003","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_269626006","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_269634000","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_363346000","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_38807002","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_372087000","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_86049000","Deficiency of L-Carnitine has been proposed to cause cancer cachexia."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_154475002","Conclusion: While these data are preliminary and need confirmation they indicate that patients with pancreatic cancer may have a clinically relevant benefit from the inexpensive and well tolerated oral supplementation of L-Carnitine."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_255089009","Conclusion: While these data are preliminary and need confirmation they indicate that patients with pancreatic cancer may have a clinically relevant benefit from the inexpensive and well tolerated oral supplementation of L-Carnitine."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_372142002","Conclusion: While these data are preliminary and need confirmation they indicate that patients with pancreatic cancer may have a clinically relevant benefit from the inexpensive and well tolerated oral supplementation of L-Carnitine."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_93938001","Conclusion: While these data are preliminary and need confirmation they indicate that patients with pancreatic cancer may have a clinically relevant benefit from the inexpensive and well tolerated oral supplementation of L-Carnitine."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_154479008","Conclusion: While these data are preliminary and need confirmation they indicate that patients with pancreatic cancer may have a clinically relevant benefit from the inexpensive and well tolerated oral supplementation of L-Carnitine."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_363418001","Conclusion: While these data are preliminary and need confirmation they indicate that patients with pancreatic cancer may have a clinically relevant benefit from the inexpensive and well tolerated oral supplementation of L-Carnitine."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_187800001","Conclusion: While these data are preliminary and need confirmation they indicate that patients with pancreatic cancer may have a clinically relevant benefit from the inexpensive and well tolerated oral supplementation of L-Carnitine."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_269556009","Conclusion: While these data are preliminary and need confirmation they indicate that patients with pancreatic cancer may have a clinically relevant benefit from the inexpensive and well tolerated oral supplementation of L-Carnitine."
"https://www.kegg.jp/entry/C00182","http://www.ihtsdo.org/SCT_64572001","Purpose of review: Glycogen storage disorders (GSDs) are inborn errors of metabolism with abnormal storage or utilization of glycogen."
"https://www.kegg.jp/entry/C00182","http://www.ihtsdo.org/SCT_363205007","Purpose of review: Glycogen storage disorders (GSDs) are inborn errors of metabolism with abnormal storage or utilization of glycogen."
"https://www.kegg.jp/entry/C00182","http://www.ihtsdo.org/SCT_86095007","Purpose of review: Glycogen storage disorders (GSDs) are inborn errors of metabolism with abnormal storage or utilization of glycogen."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_370992007","Results: Pectin supplementation reversed body and fat weight gain, dyslipidemia, hyperglycemia and insulin resistance in p,p'-DDE-exposed mice."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_144187006","Results: Pectin supplementation reversed body and fat weight gain, dyslipidemia, hyperglycemia and insulin resistance in p,p'-DDE-exposed mice."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_154719004","Results: Pectin supplementation reversed body and fat weight gain, dyslipidemia, hyperglycemia and insulin resistance in p,p'-DDE-exposed mice."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_207289007","Results: Pectin supplementation reversed body and fat weight gain, dyslipidemia, hyperglycemia and insulin resistance in p,p'-DDE-exposed mice."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_207643008","Results: Pectin supplementation reversed body and fat weight gain, dyslipidemia, hyperglycemia and insulin resistance in p,p'-DDE-exposed mice."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_237598005","Results: Pectin supplementation reversed body and fat weight gain, dyslipidemia, hyperglycemia and insulin resistance in p,p'-DDE-exposed mice."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_270004003","Results: Pectin supplementation reversed body and fat weight gain, dyslipidemia, hyperglycemia and insulin resistance in p,p'-DDE-exposed mice."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_315299009","Results: Pectin supplementation reversed body and fat weight gain, dyslipidemia, hyperglycemia and insulin resistance in p,p'-DDE-exposed mice."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_390730002","Results: Pectin supplementation reversed body and fat weight gain, dyslipidemia, hyperglycemia and insulin resistance in p,p'-DDE-exposed mice."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_80394007","Results: Pectin supplementation reversed body and fat weight gain, dyslipidemia, hyperglycemia and insulin resistance in p,p'-DDE-exposed mice."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_48606007","Results: Pectin supplementation reversed body and fat weight gain, dyslipidemia, hyperglycemia and insulin resistance in p,p'-DDE-exposed mice."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_414916001","Conclusions: Pectin had a good effect on reducing p,p'-DDE-induced obesity through regulating gut microbiota and provided a potential strategy for the treatment of environmental pollutant-caused health problems."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_154776002","Conclusions: Pectin had a good effect on reducing p,p'-DDE-induced obesity through regulating gut microbiota and provided a potential strategy for the treatment of environmental pollutant-caused health problems."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_190963004","Conclusions: Pectin had a good effect on reducing p,p'-DDE-induced obesity through regulating gut microbiota and provided a potential strategy for the treatment of environmental pollutant-caused health problems."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_414915002","Conclusions: Pectin had a good effect on reducing p,p'-DDE-induced obesity through regulating gut microbiota and provided a potential strategy for the treatment of environmental pollutant-caused health problems."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_5476005","Conclusions: Pectin had a good effect on reducing p,p'-DDE-induced obesity through regulating gut microbiota and provided a potential strategy for the treatment of environmental pollutant-caused health problems."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_414916001","Pectin reduces environmental pollutant-induced obesity in mice through regulating gut microbiota: A case study of p,p&#39;-DDE"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_154776002","Pectin reduces environmental pollutant-induced obesity in mice through regulating gut microbiota: A case study of p,p&#39;-DDE"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_190963004","Pectin reduces environmental pollutant-induced obesity in mice through regulating gut microbiota: A case study of p,p&#39;-DDE"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_414915002","Pectin reduces environmental pollutant-induced obesity in mice through regulating gut microbiota: A case study of p,p&#39;-DDE"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_5476005","Pectin reduces environmental pollutant-induced obesity in mice through regulating gut microbiota: A case study of p,p&#39;-DDE"
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_414916001","Moreover, plasma OT level was lower in FAD women with obesity than in NFA subjects (p = 0.02)."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_154776002","Moreover, plasma OT level was lower in FAD women with obesity than in NFA subjects (p = 0.02)."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_190963004","Moreover, plasma OT level was lower in FAD women with obesity than in NFA subjects (p = 0.02)."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_414915002","Moreover, plasma OT level was lower in FAD women with obesity than in NFA subjects (p = 0.02)."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_5476005","Moreover, plasma OT level was lower in FAD women with obesity than in NFA subjects (p = 0.02)."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_129453003","Folic acid is an important vitamin in human nutrition and its deficiency in pregnant women's diets results in neural tube defects and other neurological damage to the fetus."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_246199000","Folic acid is an important vitamin in human nutrition and its deficiency in pregnant women's diets results in neural tube defects and other neurological damage to the fetus."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_260372006","Folic acid is an important vitamin in human nutrition and its deficiency in pregnant women's diets results in neural tube defects and other neurological damage to the fetus."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_154722002","Folic acid is an important vitamin in human nutrition and its deficiency in pregnant women's diets results in neural tube defects and other neurological damage to the fetus."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_154730001","Folic acid is an important vitamin in human nutrition and its deficiency in pregnant women's diets results in neural tube defects and other neurological damage to the fetus."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_190595009","Folic acid is an important vitamin in human nutrition and its deficiency in pregnant women's diets results in neural tube defects and other neurological damage to the fetus."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_190608007","Folic acid is an important vitamin in human nutrition and its deficiency in pregnant women's diets results in neural tube defects and other neurological damage to the fetus."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_190678008","Folic acid is an important vitamin in human nutrition and its deficiency in pregnant women's diets results in neural tube defects and other neurological damage to the fetus."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_238106006","Folic acid is an important vitamin in human nutrition and its deficiency in pregnant women's diets results in neural tube defects and other neurological damage to the fetus."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_248325000","Folic acid is an important vitamin in human nutrition and its deficiency in pregnant women's diets results in neural tube defects and other neurological damage to the fetus."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_2492009","Folic acid is an important vitamin in human nutrition and its deficiency in pregnant women's diets results in neural tube defects and other neurological damage to the fetus."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_267409003","Folic acid is an important vitamin in human nutrition and its deficiency in pregnant women's diets results in neural tube defects and other neurological damage to the fetus."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_267495004","Folic acid is an important vitamin in human nutrition and its deficiency in pregnant women's diets results in neural tube defects and other neurological damage to the fetus."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_302868002","Folic acid is an important vitamin in human nutrition and its deficiency in pregnant women's diets results in neural tube defects and other neurological damage to the fetus."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_47563007","Folic acid is an important vitamin in human nutrition and its deficiency in pregnant women's diets results in neural tube defects and other neurological damage to the fetus."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_65404009","Folic acid is an important vitamin in human nutrition and its deficiency in pregnant women's diets results in neural tube defects and other neurological damage to the fetus."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_70241007","Folic acid is an important vitamin in human nutrition and its deficiency in pregnant women's diets results in neural tube defects and other neurological damage to the fetus."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_253098009","Folic acid is an important vitamin in human nutrition and its deficiency in pregnant women's diets results in neural tube defects and other neurological damage to the fetus."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_128239009","Folic acid is an important vitamin in human nutrition and its deficiency in pregnant women's diets results in neural tube defects and other neurological damage to the fetus."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_3325005","Glycine Attenuates LPS-Induced Apoptosis and Inflammatory Cell Infiltration in Mouse Liver"
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_79261008","Glycine Attenuates LPS-Induced Apoptosis and Inflammatory Cell Infiltration in Mouse Liver"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_154798006","Homocysteine is associated with severity of microvasculopathy in sickle cell disease patients"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_191194009","Homocysteine is associated with severity of microvasculopathy in sickle cell disease patients"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_276267006","Homocysteine is associated with severity of microvasculopathy in sickle cell disease patients"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_80046004","Homocysteine is associated with severity of microvasculopathy in sickle cell disease patients"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_191195005","Homocysteine is associated with severity of microvasculopathy in sickle cell disease patients"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_191199004","Homocysteine is associated with severity of microvasculopathy in sickle cell disease patients"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_417357006","Homocysteine is associated with severity of microvasculopathy in sickle cell disease patients"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_127040003","Homocysteine is associated with severity of microvasculopathy in sickle cell disease patients"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_156106005","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_156109003","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_198972006","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_198979002","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_199011002","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_267306006","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_288201007","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_398254007","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_6758009","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_46764007","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_15394000","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_237280005","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_46714000","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_116223007","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_198908009","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_267198008","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_35898002","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_360561001","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_415105001","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_405736009","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_156102007","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_198909001","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_198913008","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_156185006","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_206166000","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_22033007","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_267337006","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_268815007","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_386639001","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_70317007","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_198768001","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_267297005","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_156070002","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_156079001","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_156096000","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_198769009","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_198805006","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_200480007","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_363681007","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_198780009","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_198880003","Background: Homocysteine is an intermediate metabolite implicated in the risk of placenta-mediated complications, including preeclampsia, placental abruption, fetal growth restriction, and pregnancy loss."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_339947000","Leucine coingestion further augments the postexercise muscle protein synthetic response to the ingestion of a single 15-g bolus of protein in older men."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_190566000","Leucine coingestion further augments the postexercise muscle protein synthetic response to the ingestion of a single 15-g bolus of protein in older men."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_46724008","Leucine coingestion further augments the postexercise muscle protein synthetic response to the ingestion of a single 15-g bolus of protein in older men."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_60549007","Leucine coingestion further augments the postexercise muscle protein synthetic response to the ingestion of a single 15-g bolus of protein in older men."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_339947000","Leucine coingestion augments the muscle protein synthetic response to the ingestion of 15 g of protein following resistance exercise in older men"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_190566000","Leucine coingestion augments the muscle protein synthetic response to the ingestion of 15 g of protein following resistance exercise in older men"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_46724008","Leucine coingestion augments the muscle protein synthetic response to the ingestion of 15 g of protein following resistance exercise in older men"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_60549007","Leucine coingestion augments the muscle protein synthetic response to the ingestion of 15 g of protein following resistance exercise in older men"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_192180006","Homocysteine &gt;14 μmol was associated with a 272 % increased dementia risk (HR = 3.72, 95 % CI 1.06-13.08)."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_88339003","Homocysteine &gt;14 μmol was associated with a 272 % increased dementia risk (HR = 3.72, 95 % CI 1.06-13.08)."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_52448006","Homocysteine &gt;14 μmol was associated with a 272 % increased dementia risk (HR = 3.72, 95 % CI 1.06-13.08)."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_268675002","Homocysteine &gt;14 μmol was associated with a 272 % increased dementia risk (HR = 3.72, 95 % CI 1.06-13.08)."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_192180006","Homocysteine, antioxidant micronutrients and late onset dementia"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_88339003","Homocysteine, antioxidant micronutrients and late onset dementia"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_52448006","Homocysteine, antioxidant micronutrients and late onset dementia"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_268675002","Homocysteine, antioxidant micronutrients and late onset dementia"
"https://www.kegg.jp/entry/C00379","http://www.ihtsdo.org/SCT_80967001","Xylitol has been widely documented to have dental health benefits, such as reducing the risk for dental caries."
"https://www.kegg.jp/entry/C00379","http://www.ihtsdo.org/SCT_196307002","Xylitol has been widely documented to have dental health benefits, such as reducing the risk for dental caries."
"https://www.kegg.jp/entry/C00379","http://www.ihtsdo.org/SCT_155632007","Xylitol has been widely documented to have dental health benefits, such as reducing the risk for dental caries."
"https://www.kegg.jp/entry/C00379","http://www.ihtsdo.org/SCT_195745009","Xylitol also modulates the immune system, which, together with its antimicrobial activity contribute to a reduced respiratory tract infection, sinusitis, and otitis media risk."
"https://www.kegg.jp/entry/C00379","http://www.ihtsdo.org/SCT_196183006","Xylitol also modulates the immune system, which, together with its antimicrobial activity contribute to a reduced respiratory tract infection, sinusitis, and otitis media risk."
"https://www.kegg.jp/entry/C00379","http://www.ihtsdo.org/SCT_275498002","Xylitol also modulates the immune system, which, together with its antimicrobial activity contribute to a reduced respiratory tract infection, sinusitis, and otitis media risk."
"https://www.kegg.jp/entry/C00379","http://www.ihtsdo.org/SCT_36971009","Xylitol also modulates the immune system, which, together with its antimicrobial activity contribute to a reduced respiratory tract infection, sinusitis, and otitis media risk."
"https://www.kegg.jp/entry/C00379","http://www.ihtsdo.org/SCT_195649005","Xylitol also modulates the immune system, which, together with its antimicrobial activity contribute to a reduced respiratory tract infection, sinusitis, and otitis media risk."
"https://www.kegg.jp/entry/C00379","http://www.ihtsdo.org/SCT_275483004","Xylitol also modulates the immune system, which, together with its antimicrobial activity contribute to a reduced respiratory tract infection, sinusitis, and otitis media risk."
"https://www.kegg.jp/entry/C00379","http://www.ihtsdo.org/SCT_267669008","Xylitol also modulates the immune system, which, together with its antimicrobial activity contribute to a reduced respiratory tract infection, sinusitis, and otitis media risk."
"https://www.kegg.jp/entry/C00379","http://www.ihtsdo.org/SCT_65363002","Xylitol also modulates the immune system, which, together with its antimicrobial activity contribute to a reduced respiratory tract infection, sinusitis, and otitis media risk."
"https://www.kegg.jp/entry/C00379","http://www.ihtsdo.org/SCT_155222006","Xylitol also modulates the immune system, which, together with its antimicrobial activity contribute to a reduced respiratory tract infection, sinusitis, and otitis media risk."
"https://www.kegg.jp/entry/C00379","http://www.ihtsdo.org/SCT_194291009","Xylitol also modulates the immune system, which, together with its antimicrobial activity contribute to a reduced respiratory tract infection, sinusitis, and otitis media risk."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_419503008","Folic acid also ameliorates hyperhomocysteinemia, which is a consequence of elevated levels of homocysteine."
"https://www.kegg.jp/entry/C00047","http://www.ihtsdo.org/SCT_64572001","Circulating and Extracellular Vesicles Levels of N-(1-Carboxymethyl)-L-Lysine (CML) Differentiate Early to Moderate Alzheimer&#39;s Disease"
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_111375001","Conclusion: Glutamate level may represent an interesting potential biomarker of abdominal obesity and metabolic risk."
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_123291007","Conclusion: Glutamate level may represent an interesting potential biomarker of abdominal obesity and metabolic risk."
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_248311001","Conclusion: Glutamate level may represent an interesting potential biomarker of abdominal obesity and metabolic risk."
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_339947000","Glutamate was strongly correlated with WC (r = 0.66 for men; r = 0.76 for women, both p &lt; 0.0001) and multiple markers of metabolic dysfunction, particularly fasting triglyceride level (r = 0.59 for men; r = 0.57 for women, both p &lt; 0.0001), HDL-cholesterol level (r = -0.45, p &lt; 0.0001 in both sexes) and the HOMA-IR index (r = 0.65 for men; r = 0.60 for women, both p &lt; 0.0001)."
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_190566000","Glutamate was strongly correlated with WC (r = 0.66 for men; r = 0.76 for women, both p &lt; 0.0001) and multiple markers of metabolic dysfunction, particularly fasting triglyceride level (r = 0.59 for men; r = 0.57 for women, both p &lt; 0.0001), HDL-cholesterol level (r = -0.45, p &lt; 0.0001 in both sexes) and the HOMA-IR index (r = 0.65 for men; r = 0.60 for women, both p &lt; 0.0001)."
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_46724008","Glutamate was strongly correlated with WC (r = 0.66 for men; r = 0.76 for women, both p &lt; 0.0001) and multiple markers of metabolic dysfunction, particularly fasting triglyceride level (r = 0.59 for men; r = 0.57 for women, both p &lt; 0.0001), HDL-cholesterol level (r = -0.45, p &lt; 0.0001 in both sexes) and the HOMA-IR index (r = 0.65 for men; r = 0.60 for women, both p &lt; 0.0001)."
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_60549007","Glutamate was strongly correlated with WC (r = 0.66 for men; r = 0.76 for women, both p &lt; 0.0001) and multiple markers of metabolic dysfunction, particularly fasting triglyceride level (r = 0.59 for men; r = 0.57 for women, both p &lt; 0.0001), HDL-cholesterol level (r = -0.45, p &lt; 0.0001 in both sexes) and the HOMA-IR index (r = 0.65 for men; r = 0.60 for women, both p &lt; 0.0001)."
"https://www.kegg.jp/entry/C00120","http://www.ihtsdo.org/SCT_421784001","Biotin and carnitine deficiency due to hypoallergenic formula nutrition in infants with milk allergy"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_339947000","Conclusion: Homocysteine levels were positively associated and dietary folate intake was inversely associated with risk of PAD in men but not in women."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_190566000","Conclusion: Homocysteine levels were positively associated and dietary folate intake was inversely associated with risk of PAD in men but not in women."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_46724008","Conclusion: Homocysteine levels were positively associated and dietary folate intake was inversely associated with risk of PAD in men but not in women."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_60549007","Conclusion: Homocysteine levels were positively associated and dietary folate intake was inversely associated with risk of PAD in men but not in women."
"https://www.kegg.jp/entry/C00072","http://www.ihtsdo.org/SCT_32798002","Ascorbate- and zinc-responsive parkinsonism"
"https://www.kegg.jp/entry/C00072","http://www.ihtsdo.org/SCT_394962002","Ascorbate- and zinc-responsive parkinsonism"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_71677004","Vitamin D3 (cholecalciferol) can be either synthesized in the human skin upon exposure to the UV light of the sun, or it is obtained from the diet."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_217642005","Vitamin D3 (cholecalciferol) can be either synthesized in the human skin upon exposure to the UV light of the sun, or it is obtained from the diet."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_242576005","Vitamin D3 (cholecalciferol) can be either synthesized in the human skin upon exposure to the UV light of the sun, or it is obtained from the diet."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_24932003","Vitamin D3 (cholecalciferol) can be either synthesized in the human skin upon exposure to the UV light of the sun, or it is obtained from the diet."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_217645007","Vitamin D3 (cholecalciferol) can be either synthesized in the human skin upon exposure to the UV light of the sun, or it is obtained from the diet."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_242575009","Vitamin D3 (cholecalciferol) can be either synthesized in the human skin upon exposure to the UV light of the sun, or it is obtained from the diet."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_57918009","The Janus Face of Cereals: Wheat-Derived Prebiotics Counteract the Detrimental Effect of Gluten on Metabolic Homeostasis in Mice Fed a High-Fat/High-Sucrose Diet"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_422504002","Elevated Total Homocysteine Levels in Acute Ischemic Stroke Are Associated With Long-Term Mortality"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_3325005","Pectin from apple inhibits the BabA and LPS-mediated adhesion of H. pylori to human stomach cells."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_79261008","Pectin from apple inhibits the BabA and LPS-mediated adhesion of H. pylori to human stomach cells."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_154871001","Homocysteine as a potential biomarker in bipolar disorders: a critical review and suggestions for improved studies"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_192355004","Homocysteine as a potential biomarker in bipolar disorders: a critical review and suggestions for improved studies"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_268749008","Homocysteine as a potential biomarker in bipolar disorders: a critical review and suggestions for improved studies"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_13746004","Homocysteine as a potential biomarker in bipolar disorders: a critical review and suggestions for improved studies"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_191646009","Homocysteine as a potential biomarker in bipolar disorders: a critical review and suggestions for improved studies"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_192365005","Homocysteine as a potential biomarker in bipolar disorders: a critical review and suggestions for improved studies"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_191647000","Homocysteine as a potential biomarker in bipolar disorders: a critical review and suggestions for improved studies"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_191654006","Homocysteine as a potential biomarker in bipolar disorders: a critical review and suggestions for improved studies"
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_79514008","Folic acid treatment significantly reduced the risk of first ischemic stroke in participants with both folate and B&gt;sub&lt;12&gt;/sub&lt; below the median (2.3% in enalapril-folic acid group vs 3.6% in enalapril-only group; HR, 0.62; 95% CI, 0.46-0.86), particularly in &gt;i&lt;MTHFR&gt;/i&lt; 677 CC carriers (1.6% vs 4.9%; HR, 0.24; 95% CI, 0.11-0.55)."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_41797007","Folic acid treatment significantly reduced the risk of first ischemic stroke in participants with both folate and B&gt;sub&lt;12&gt;/sub&lt; below the median (2.3% in enalapril-folic acid group vs 3.6% in enalapril-only group; HR, 0.62; 95% CI, 0.46-0.86), particularly in &gt;i&lt;MTHFR&gt;/i&lt; 677 CC carriers (1.6% vs 4.9%; HR, 0.24; 95% CI, 0.11-0.55)."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_312104005","Folic acid treatment significantly reduced the risk of first ischemic stroke in participants with both folate and B&gt;sub&lt;12&gt;/sub&lt; below the median (2.3% in enalapril-folic acid group vs 3.6% in enalapril-only group; HR, 0.62; 95% CI, 0.46-0.86), particularly in &gt;i&lt;MTHFR&gt;/i&lt; 677 CC carriers (1.6% vs 4.9%; HR, 0.24; 95% CI, 0.11-0.55)."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_70179006","Folic acid treatment significantly reduced the risk of first ischemic stroke in participants with both folate and B&gt;sub&lt;12&gt;/sub&lt; below the median (2.3% in enalapril-folic acid group vs 3.6% in enalapril-only group; HR, 0.62; 95% CI, 0.46-0.86), particularly in &gt;i&lt;MTHFR&gt;/i&lt; 677 CC carriers (1.6% vs 4.9%; HR, 0.24; 95% CI, 0.11-0.55)."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_409586006","Folic acid treatment significantly reduced the risk of first ischemic stroke in participants with both folate and B&gt;sub&lt;12&gt;/sub&lt; below the median (2.3% in enalapril-folic acid group vs 3.6% in enalapril-only group; HR, 0.62; 95% CI, 0.46-0.86), particularly in &gt;i&lt;MTHFR&gt;/i&lt; 677 CC carriers (1.6% vs 4.9%; HR, 0.24; 95% CI, 0.11-0.55)."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_33962009","Folic acid treatment significantly reduced the risk of first ischemic stroke in participants with both folate and B&gt;sub&lt;12&gt;/sub&lt; below the median (2.3% in enalapril-folic acid group vs 3.6% in enalapril-only group; HR, 0.62; 95% CI, 0.46-0.86), particularly in &gt;i&lt;MTHFR&gt;/i&lt; 677 CC carriers (1.6% vs 4.9%; HR, 0.24; 95% CI, 0.11-0.55)."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_3422007","Folic acid treatment significantly reduced the risk of first ischemic stroke in participants with both folate and B&gt;sub&lt;12&gt;/sub&lt; below the median (2.3% in enalapril-folic acid group vs 3.6% in enalapril-only group; HR, 0.62; 95% CI, 0.46-0.86), particularly in &gt;i&lt;MTHFR&gt;/i&lt; 677 CC carriers (1.6% vs 4.9%; HR, 0.24; 95% CI, 0.11-0.55)."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_393452006","Folic acid treatment significantly reduced the risk of first ischemic stroke in participants with both folate and B&gt;sub&lt;12&gt;/sub&lt; below the median (2.3% in enalapril-folic acid group vs 3.6% in enalapril-only group; HR, 0.62; 95% CI, 0.46-0.86), particularly in &gt;i&lt;MTHFR&gt;/i&lt; 677 CC carriers (1.6% vs 4.9%; HR, 0.24; 95% CI, 0.11-0.55)."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_394402008","Folic acid treatment significantly reduced the risk of first ischemic stroke in participants with both folate and B&gt;sub&lt;12&gt;/sub&lt; below the median (2.3% in enalapril-folic acid group vs 3.6% in enalapril-only group; HR, 0.62; 95% CI, 0.46-0.86), particularly in &gt;i&lt;MTHFR&gt;/i&lt; 677 CC carriers (1.6% vs 4.9%; HR, 0.24; 95% CI, 0.11-0.55)."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_394917001","Folic acid treatment significantly reduced the risk of first ischemic stroke in participants with both folate and B&gt;sub&lt;12&gt;/sub&lt; below the median (2.3% in enalapril-folic acid group vs 3.6% in enalapril-only group; HR, 0.62; 95% CI, 0.46-0.86), particularly in &gt;i&lt;MTHFR&gt;/i&lt; 677 CC carriers (1.6% vs 4.9%; HR, 0.24; 95% CI, 0.11-0.55)."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_258773002","Folic acid treatment significantly reduced the risk of first ischemic stroke in participants with both folate and B&gt;sub&lt;12&gt;/sub&lt; below the median (2.3% in enalapril-folic acid group vs 3.6% in enalapril-only group; HR, 0.62; 95% CI, 0.46-0.86), particularly in &gt;i&lt;MTHFR&gt;/i&lt; 677 CC carriers (1.6% vs 4.9%; HR, 0.24; 95% CI, 0.11-0.55)."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_422504002","Folic acid treatment significantly reduced the risk of first ischemic stroke in participants with both folate and B&gt;sub&lt;12&gt;/sub&lt; below the median (2.3% in enalapril-folic acid group vs 3.6% in enalapril-only group; HR, 0.62; 95% CI, 0.46-0.86), particularly in &gt;i&lt;MTHFR&gt;/i&lt; 677 CC carriers (1.6% vs 4.9%; HR, 0.24; 95% CI, 0.11-0.55)."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_339947000","Leucine-enriched amino acid ingestion after resistance exercise prolongs myofibrillar protein synthesis and amino acid transporter expression in older men"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_190566000","Leucine-enriched amino acid ingestion after resistance exercise prolongs myofibrillar protein synthesis and amino acid transporter expression in older men"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_46724008","Leucine-enriched amino acid ingestion after resistance exercise prolongs myofibrillar protein synthesis and amino acid transporter expression in older men"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_60549007","Leucine-enriched amino acid ingestion after resistance exercise prolongs myofibrillar protein synthesis and amino acid transporter expression in older men"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_10200004","Leucine restriction (LR) also improved glucose tolerance, increased hepatic release of fibroblast growth factor 21 into the blood stream, and enhanced insulin-dependent activation of Akt in liver."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_155807008","Leucine restriction (LR) also improved glucose tolerance, increased hepatic release of fibroblast growth factor 21 into the blood stream, and enhanced insulin-dependent activation of Akt in liver."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_155817003","Leucine restriction (LR) also improved glucose tolerance, increased hepatic release of fibroblast growth factor 21 into the blood stream, and enhanced insulin-dependent activation of Akt in liver."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_155822003","Leucine restriction (LR) also improved glucose tolerance, increased hepatic release of fibroblast growth factor 21 into the blood stream, and enhanced insulin-dependent activation of Akt in liver."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_197375001","Leucine restriction (LR) also improved glucose tolerance, increased hepatic release of fibroblast growth factor 21 into the blood stream, and enhanced insulin-dependent activation of Akt in liver."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_197551000","Leucine restriction (LR) also improved glucose tolerance, increased hepatic release of fibroblast growth factor 21 into the blood stream, and enhanced insulin-dependent activation of Akt in liver."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_235856003","Leucine restriction (LR) also improved glucose tolerance, increased hepatic release of fibroblast growth factor 21 into the blood stream, and enhanced insulin-dependent activation of Akt in liver."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_266535008","Leucine restriction (LR) also improved glucose tolerance, increased hepatic release of fibroblast growth factor 21 into the blood stream, and enhanced insulin-dependent activation of Akt in liver."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_62857009","Leucine restriction (LR) also improved glucose tolerance, increased hepatic release of fibroblast growth factor 21 into the blood stream, and enhanced insulin-dependent activation of Akt in liver."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_412238008","Leucine restriction (LR) also improved glucose tolerance, increased hepatic release of fibroblast growth factor 21 into the blood stream, and enhanced insulin-dependent activation of Akt in liver."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_88566002","Leucine restriction (LR) also improved glucose tolerance, increased hepatic release of fibroblast growth factor 21 into the blood stream, and enhanced insulin-dependent activation of Akt in liver."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_190394009","&quot;Sucrose, fructose, glucose and their link to metabolic syndrome and cancer&quot;"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_237602007","&quot;Sucrose, fructose, glucose and their link to metabolic syndrome and cancer&quot;"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_154432008","&quot;Sucrose, fructose, glucose and their link to metabolic syndrome and cancer&quot;"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_154433003","&quot;Sucrose, fructose, glucose and their link to metabolic syndrome and cancer&quot;"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_154577008","&quot;Sucrose, fructose, glucose and their link to metabolic syndrome and cancer&quot;"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_187597000","&quot;Sucrose, fructose, glucose and their link to metabolic syndrome and cancer&quot;"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_188475001","&quot;Sucrose, fructose, glucose and their link to metabolic syndrome and cancer&quot;"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_188482002","&quot;Sucrose, fructose, glucose and their link to metabolic syndrome and cancer&quot;"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_190150006","&quot;Sucrose, fructose, glucose and their link to metabolic syndrome and cancer&quot;"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_269513004","&quot;Sucrose, fructose, glucose and their link to metabolic syndrome and cancer&quot;"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_269623003","&quot;Sucrose, fructose, glucose and their link to metabolic syndrome and cancer&quot;"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_269626006","&quot;Sucrose, fructose, glucose and their link to metabolic syndrome and cancer&quot;"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_269634000","&quot;Sucrose, fructose, glucose and their link to metabolic syndrome and cancer&quot;"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_363346000","&quot;Sucrose, fructose, glucose and their link to metabolic syndrome and cancer&quot;"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_38807002","&quot;Sucrose, fructose, glucose and their link to metabolic syndrome and cancer&quot;"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_372087000","&quot;Sucrose, fructose, glucose and their link to metabolic syndrome and cancer&quot;"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_86049000","&quot;Sucrose, fructose, glucose and their link to metabolic syndrome and cancer&quot;"
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_42399005","Thiamine, a water-soluble vitamin also known as vitamin B1, is a critical cofactor in energy metabolism and may be competitively inhibited by the antimetabolite oxythiamine, a uremic toxin that accumulates in kidney failure."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_156092003","Thiamine, a water-soluble vitamin also known as vitamin B1, is a critical cofactor in energy metabolism and may be competitively inhibited by the antimetabolite oxythiamine, a uremic toxin that accumulates in kidney failure."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_197656003","Thiamine, a water-soluble vitamin also known as vitamin B1, is a critical cofactor in energy metabolism and may be competitively inhibited by the antimetabolite oxythiamine, a uremic toxin that accumulates in kidney failure."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_198524000","Thiamine, a water-soluble vitamin also known as vitamin B1, is a critical cofactor in energy metabolism and may be competitively inhibited by the antimetabolite oxythiamine, a uremic toxin that accumulates in kidney failure."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_266553002","Thiamine, a water-soluble vitamin also known as vitamin B1, is a critical cofactor in energy metabolism and may be competitively inhibited by the antimetabolite oxythiamine, a uremic toxin that accumulates in kidney failure."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_266616000","Thiamine, a water-soluble vitamin also known as vitamin B1, is a critical cofactor in energy metabolism and may be competitively inhibited by the antimetabolite oxythiamine, a uremic toxin that accumulates in kidney failure."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_723188008","Thiamine, a water-soluble vitamin also known as vitamin B1, is a critical cofactor in energy metabolism and may be competitively inhibited by the antimetabolite oxythiamine, a uremic toxin that accumulates in kidney failure."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_204017003","Results: Folic acid interventions in Ethiopia would have prevented about 41,610 cases of folic acid-preventable spina bifida and anencephaly-affected pregnancies during the year 2016."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_156888006","Results: Folic acid interventions in Ethiopia would have prevented about 41,610 cases of folic acid-preventable spina bifida and anencephaly-affected pregnancies during the year 2016."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_67531005","Results: Folic acid interventions in Ethiopia would have prevented about 41,610 cases of folic acid-preventable spina bifida and anencephaly-affected pregnancies during the year 2016."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_203960000","Results: Folic acid interventions in Ethiopia would have prevented about 41,610 cases of folic acid-preventable spina bifida and anencephaly-affected pregnancies during the year 2016."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_203962008","Results: Folic acid interventions in Ethiopia would have prevented about 41,610 cases of folic acid-preventable spina bifida and anencephaly-affected pregnancies during the year 2016."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_203966006","Results: Folic acid interventions in Ethiopia would have prevented about 41,610 cases of folic acid-preventable spina bifida and anencephaly-affected pregnancies during the year 2016."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_268145008","Results: Folic acid interventions in Ethiopia would have prevented about 41,610 cases of folic acid-preventable spina bifida and anencephaly-affected pregnancies during the year 2016."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_268149002","Results: Folic acid interventions in Ethiopia would have prevented about 41,610 cases of folic acid-preventable spina bifida and anencephaly-affected pregnancies during the year 2016."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_156890007","Results: Folic acid interventions in Ethiopia would have prevented about 41,610 cases of folic acid-preventable spina bifida and anencephaly-affected pregnancies during the year 2016."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_203961001","Results: Folic acid interventions in Ethiopia would have prevented about 41,610 cases of folic acid-preventable spina bifida and anencephaly-affected pregnancies during the year 2016."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_204016007","Results: Folic acid interventions in Ethiopia would have prevented about 41,610 cases of folic acid-preventable spina bifida and anencephaly-affected pregnancies during the year 2016."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_268308005","Results: Folic acid interventions in Ethiopia would have prevented about 41,610 cases of folic acid-preventable spina bifida and anencephaly-affected pregnancies during the year 2016."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_203926007","Results: Folic acid interventions in Ethiopia would have prevented about 41,610 cases of folic acid-preventable spina bifida and anencephaly-affected pregnancies during the year 2016."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_156885009","Results: Folic acid interventions in Ethiopia would have prevented about 41,610 cases of folic acid-preventable spina bifida and anencephaly-affected pregnancies during the year 2016."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_156887001","Results: Folic acid interventions in Ethiopia would have prevented about 41,610 cases of folic acid-preventable spina bifida and anencephaly-affected pregnancies during the year 2016."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_268306009","Results: Folic acid interventions in Ethiopia would have prevented about 41,610 cases of folic acid-preventable spina bifida and anencephaly-affected pregnancies during the year 2016."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_89369001","Results: Folic acid interventions in Ethiopia would have prevented about 41,610 cases of folic acid-preventable spina bifida and anencephaly-affected pregnancies during the year 2016."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_154313001","Update to the Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) protocol: statistical analysis plan for a prospective, multicenter, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial"
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_186392004","Update to the Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) protocol: statistical analysis plan for a prospective, multicenter, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial"
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_40555009","Update to the Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) protocol: statistical analysis plan for a prospective, multicenter, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial"
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_91302008","Update to the Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) protocol: statistical analysis plan for a prospective, multicenter, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial"
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_105592009","Update to the Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) protocol: statistical analysis plan for a prospective, multicenter, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial"
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_187333004","Update to the Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) protocol: statistical analysis plan for a prospective, multicenter, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial"
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_266089004","Update to the Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) protocol: statistical analysis plan for a prospective, multicenter, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial"
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_445101001","Update to the Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) protocol: statistical analysis plan for a prospective, multicenter, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial"
"https://www.kegg.jp/entry/C00255","http://www.ihtsdo.org/SCT_154786001","Suboptimal Biochemical Riboflavin Status Is Associated with Lower Hemoglobin and Higher Rates of Anemia in a Sample of Canadian and Malaysian Women of Reproductive Age"
"https://www.kegg.jp/entry/C00255","http://www.ihtsdo.org/SCT_154812000","Suboptimal Biochemical Riboflavin Status Is Associated with Lower Hemoglobin and Higher Rates of Anemia in a Sample of Canadian and Malaysian Women of Reproductive Age"
"https://www.kegg.jp/entry/C00255","http://www.ihtsdo.org/SCT_191277004","Suboptimal Biochemical Riboflavin Status Is Associated with Lower Hemoglobin and Higher Rates of Anemia in a Sample of Canadian and Malaysian Women of Reproductive Age"
"https://www.kegg.jp/entry/C00255","http://www.ihtsdo.org/SCT_267531008","Suboptimal Biochemical Riboflavin Status Is Associated with Lower Hemoglobin and Higher Rates of Anemia in a Sample of Canadian and Malaysian Women of Reproductive Age"
"https://www.kegg.jp/entry/C00255","http://www.ihtsdo.org/SCT_64593003","Suboptimal Biochemical Riboflavin Status Is Associated with Lower Hemoglobin and Higher Rates of Anemia in a Sample of Canadian and Malaysian Women of Reproductive Age"
"https://www.kegg.jp/entry/C00255","http://www.ihtsdo.org/SCT_271737000","Suboptimal Biochemical Riboflavin Status Is Associated with Lower Hemoglobin and Higher Rates of Anemia in a Sample of Canadian and Malaysian Women of Reproductive Age"
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_64572001","Background and aims: Glutamate, glutamine are involved in energy metabolism, and have been related to cardiometabolic disorders."
"https://www.kegg.jp/entry/C00369","http://www.ihtsdo.org/SCT_2911006","Starch digestibility was lower (&gt;i&lt;p&gt;/i&lt; &lt; 0.05) for dogs fed the basic diet + corn meal."
"https://www.kegg.jp/entry/C00369","http://www.ihtsdo.org/SCT_46014006","Starch digestibility was lower (&gt;i&lt;p&gt;/i&lt; &lt; 0.05) for dogs fed the basic diet + corn meal."
"https://www.kegg.jp/entry/C00369","http://www.ihtsdo.org/SCT_201038005","Starch digestibility was lower (&gt;i&lt;p&gt;/i&lt; &lt; 0.05) for dogs fed the basic diet + corn meal."
"https://www.kegg.jp/entry/C00369","http://www.ihtsdo.org/SCT_201039002","Starch digestibility was lower (&gt;i&lt;p&gt;/i&lt; &lt; 0.05) for dogs fed the basic diet + corn meal."
"https://www.kegg.jp/entry/C00369","http://www.ihtsdo.org/SCT_2447002","Starch digestibility was lower (&gt;i&lt;p&gt;/i&lt; &lt; 0.05) for dogs fed the basic diet + corn meal."
"https://www.kegg.jp/entry/C00369","http://www.ihtsdo.org/SCT_412357001","Starch digestibility was lower (&gt;i&lt;p&gt;/i&lt; &lt; 0.05) for dogs fed the basic diet + corn meal."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_166702002","A Diet Rich in Fish Oil and Leucine Ameliorates Hypercalcemia in Tumour-Induced Cachectic Mice"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_154752005","A Diet Rich in Fish Oil and Leucine Ameliorates Hypercalcemia in Tumour-Induced Cachectic Mice"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_267505006","A Diet Rich in Fish Oil and Leucine Ameliorates Hypercalcemia in Tumour-Induced Cachectic Mice"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_66931009","A Diet Rich in Fish Oil and Leucine Ameliorates Hypercalcemia in Tumour-Induced Cachectic Mice"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_154634001","A Diet Rich in Fish Oil and Leucine Ameliorates Hypercalcemia in Tumour-Induced Cachectic Mice"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_154645003","A Diet Rich in Fish Oil and Leucine Ameliorates Hypercalcemia in Tumour-Induced Cachectic Mice"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_154646002","A Diet Rich in Fish Oil and Leucine Ameliorates Hypercalcemia in Tumour-Induced Cachectic Mice"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_190230000","A Diet Rich in Fish Oil and Leucine Ameliorates Hypercalcemia in Tumour-Induced Cachectic Mice"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_187597000","A Diet Rich in Fish Oil and Leucine Ameliorates Hypercalcemia in Tumour-Induced Cachectic Mice"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_108369006","A Diet Rich in Fish Oil and Leucine Ameliorates Hypercalcemia in Tumour-Induced Cachectic Mice"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_189542002","A Diet Rich in Fish Oil and Leucine Ameliorates Hypercalcemia in Tumour-Induced Cachectic Mice"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_86251006","A Diet Rich in Fish Oil and Leucine Ameliorates Hypercalcemia in Tumour-Induced Cachectic Mice"
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_107656002","Folic acid concentrations increased and the percentage of individuals with glucose (40.4% to 3.7%), triglycerides (38% to 7.4%), HDL cholesterol (31 % to 7.4%) and uric acid (70.5% to 11.1%) abnormalities reduced."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_112635002","Folic acid concentrations increased and the percentage of individuals with glucose (40.4% to 3.7%), triglycerides (38% to 7.4%), HDL cholesterol (31 % to 7.4%) and uric acid (70.5% to 11.1%) abnormalities reduced."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_157028001","Folic acid concentrations increased and the percentage of individuals with glucose (40.4% to 3.7%), triglycerides (38% to 7.4%), HDL cholesterol (31 % to 7.4%) and uric acid (70.5% to 11.1%) abnormalities reduced."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_157033002","Folic acid concentrations increased and the percentage of individuals with glucose (40.4% to 3.7%), triglycerides (38% to 7.4%), HDL cholesterol (31 % to 7.4%) and uric acid (70.5% to 11.1%) abnormalities reduced."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_157034008","Folic acid concentrations increased and the percentage of individuals with glucose (40.4% to 3.7%), triglycerides (38% to 7.4%), HDL cholesterol (31 % to 7.4%) and uric acid (70.5% to 11.1%) abnormalities reduced."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_205842001","Folic acid concentrations increased and the percentage of individuals with glucose (40.4% to 3.7%), triglycerides (38% to 7.4%), HDL cholesterol (31 % to 7.4%) and uric acid (70.5% to 11.1%) abnormalities reduced."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_205999005","Folic acid concentrations increased and the percentage of individuals with glucose (40.4% to 3.7%), triglycerides (38% to 7.4%), HDL cholesterol (31 % to 7.4%) and uric acid (70.5% to 11.1%) abnormalities reduced."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_21390004","Folic acid concentrations increased and the percentage of individuals with glucose (40.4% to 3.7%), triglycerides (38% to 7.4%), HDL cholesterol (31 % to 7.4%) and uric acid (70.5% to 11.1%) abnormalities reduced."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_268359006","Folic acid concentrations increased and the percentage of individuals with glucose (40.4% to 3.7%), triglycerides (38% to 7.4%), HDL cholesterol (31 % to 7.4%) and uric acid (70.5% to 11.1%) abnormalities reduced."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_276654001","Folic acid concentrations increased and the percentage of individuals with glucose (40.4% to 3.7%), triglycerides (38% to 7.4%), HDL cholesterol (31 % to 7.4%) and uric acid (70.5% to 11.1%) abnormalities reduced."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_276655000","Folic acid concentrations increased and the percentage of individuals with glucose (40.4% to 3.7%), triglycerides (38% to 7.4%), HDL cholesterol (31 % to 7.4%) and uric acid (70.5% to 11.1%) abnormalities reduced."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_385297003","Folic acid concentrations increased and the percentage of individuals with glucose (40.4% to 3.7%), triglycerides (38% to 7.4%), HDL cholesterol (31 % to 7.4%) and uric acid (70.5% to 11.1%) abnormalities reduced."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_443341004","Folic acid concentrations increased and the percentage of individuals with glucose (40.4% to 3.7%), triglycerides (38% to 7.4%), HDL cholesterol (31 % to 7.4%) and uric acid (70.5% to 11.1%) abnormalities reduced."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_66091009","Folic acid concentrations increased and the percentage of individuals with glucose (40.4% to 3.7%), triglycerides (38% to 7.4%), HDL cholesterol (31 % to 7.4%) and uric acid (70.5% to 11.1%) abnormalities reduced."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_414916001","Leucine, a branched amino acid, has anti-obesity effects on glucose tolerance, lipid metabolism, and insulin sensitivity."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_154776002","Leucine, a branched amino acid, has anti-obesity effects on glucose tolerance, lipid metabolism, and insulin sensitivity."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_190963004","Leucine, a branched amino acid, has anti-obesity effects on glucose tolerance, lipid metabolism, and insulin sensitivity."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_414915002","Leucine, a branched amino acid, has anti-obesity effects on glucose tolerance, lipid metabolism, and insulin sensitivity."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_5476005","Leucine, a branched amino acid, has anti-obesity effects on glucose tolerance, lipid metabolism, and insulin sensitivity."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_414916001","Leucine also modulates mitochondrial dysfunction, representing a new strategy to target aging, neurodegenerative disease, obesity, diabetes, and cardiovascular disease."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_154776002","Leucine also modulates mitochondrial dysfunction, representing a new strategy to target aging, neurodegenerative disease, obesity, diabetes, and cardiovascular disease."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_190963004","Leucine also modulates mitochondrial dysfunction, representing a new strategy to target aging, neurodegenerative disease, obesity, diabetes, and cardiovascular disease."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_414915002","Leucine also modulates mitochondrial dysfunction, representing a new strategy to target aging, neurodegenerative disease, obesity, diabetes, and cardiovascular disease."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_5476005","Leucine also modulates mitochondrial dysfunction, representing a new strategy to target aging, neurodegenerative disease, obesity, diabetes, and cardiovascular disease."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_154671004","Leucine also modulates mitochondrial dysfunction, representing a new strategy to target aging, neurodegenerative disease, obesity, diabetes, and cardiovascular disease."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_191044006","Leucine also modulates mitochondrial dysfunction, representing a new strategy to target aging, neurodegenerative disease, obesity, diabetes, and cardiovascular disease."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_267467004","Leucine also modulates mitochondrial dysfunction, representing a new strategy to target aging, neurodegenerative disease, obesity, diabetes, and cardiovascular disease."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_73211009","Leucine also modulates mitochondrial dysfunction, representing a new strategy to target aging, neurodegenerative disease, obesity, diabetes, and cardiovascular disease."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_155263000","Leucine also modulates mitochondrial dysfunction, representing a new strategy to target aging, neurodegenerative disease, obesity, diabetes, and cardiovascular disease."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_194707003","Leucine also modulates mitochondrial dysfunction, representing a new strategy to target aging, neurodegenerative disease, obesity, diabetes, and cardiovascular disease."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_195139006","Leucine also modulates mitochondrial dysfunction, representing a new strategy to target aging, neurodegenerative disease, obesity, diabetes, and cardiovascular disease."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_195594006","Leucine also modulates mitochondrial dysfunction, representing a new strategy to target aging, neurodegenerative disease, obesity, diabetes, and cardiovascular disease."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_266275004","Leucine also modulates mitochondrial dysfunction, representing a new strategy to target aging, neurodegenerative disease, obesity, diabetes, and cardiovascular disease."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_266336005","Leucine also modulates mitochondrial dysfunction, representing a new strategy to target aging, neurodegenerative disease, obesity, diabetes, and cardiovascular disease."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_49601007","Leucine also modulates mitochondrial dysfunction, representing a new strategy to target aging, neurodegenerative disease, obesity, diabetes, and cardiovascular disease."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_414916001","Sucrose consumption can cause obesity and nonalcoholic fatty liver disease (NAFLD)."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_154776002","Sucrose consumption can cause obesity and nonalcoholic fatty liver disease (NAFLD)."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_190963004","Sucrose consumption can cause obesity and nonalcoholic fatty liver disease (NAFLD)."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_414915002","Sucrose consumption can cause obesity and nonalcoholic fatty liver disease (NAFLD)."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_5476005","Sucrose consumption can cause obesity and nonalcoholic fatty liver disease (NAFLD)."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_371329005","Sucrose consumption can cause obesity and nonalcoholic fatty liver disease (NAFLD)."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_5360002","Sucrose consumption can cause obesity and nonalcoholic fatty liver disease (NAFLD)."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_197315008","Sucrose consumption can cause obesity and nonalcoholic fatty liver disease (NAFLD)."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_154313001","The Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial"
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_186392004","The Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial"
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_40555009","The Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial"
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_91302008","The Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial"
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_105592009","The Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial"
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_187333004","The Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial"
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_266089004","The Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial"
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_445101001","The Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_235956004","Sucrose content was higher in HP and TD than in SD green coffees."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_68072000","Sucrose content was higher in HP and TD than in SD green coffees."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_62047007","Sucrose content was higher in HP and TD than in SD green coffees."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_277163006","Sucrose content was higher in HP and TD than in SD green coffees."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_414916001","Highly Branched RG-I Domain Enrichment Is Indispensable for Pectin Mitigating against High-Fat Diet-Induced Obesity"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_154776002","Highly Branched RG-I Domain Enrichment Is Indispensable for Pectin Mitigating against High-Fat Diet-Induced Obesity"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_190963004","Highly Branched RG-I Domain Enrichment Is Indispensable for Pectin Mitigating against High-Fat Diet-Induced Obesity"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_414915002","Highly Branched RG-I Domain Enrichment Is Indispensable for Pectin Mitigating against High-Fat Diet-Induced Obesity"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_5476005","Highly Branched RG-I Domain Enrichment Is Indispensable for Pectin Mitigating against High-Fat Diet-Induced Obesity"
"https://www.kegg.jp/entry/C00147","http://www.ihtsdo.org/SCT_139391008","Adenine-treated animals experienced weight-loss, polyuria and polydipsia; however, these effects were significantly attenuated in adenine-treated Gunn rats."
"https://www.kegg.jp/entry/C00147","http://www.ihtsdo.org/SCT_139462009","Adenine-treated animals experienced weight-loss, polyuria and polydipsia; however, these effects were significantly attenuated in adenine-treated Gunn rats."
"https://www.kegg.jp/entry/C00147","http://www.ihtsdo.org/SCT_158474005","Adenine-treated animals experienced weight-loss, polyuria and polydipsia; however, these effects were significantly attenuated in adenine-treated Gunn rats."
"https://www.kegg.jp/entry/C00147","http://www.ihtsdo.org/SCT_162114000","Adenine-treated animals experienced weight-loss, polyuria and polydipsia; however, these effects were significantly attenuated in adenine-treated Gunn rats."
"https://www.kegg.jp/entry/C00147","http://www.ihtsdo.org/SCT_718402002","Adenine-treated animals experienced weight-loss, polyuria and polydipsia; however, these effects were significantly attenuated in adenine-treated Gunn rats."
"https://www.kegg.jp/entry/C00147","http://www.ihtsdo.org/SCT_56574000","Adenine-treated animals experienced weight-loss, polyuria and polydipsia; however, these effects were significantly attenuated in adenine-treated Gunn rats."
"https://www.kegg.jp/entry/C00147","http://www.ihtsdo.org/SCT_207177002","Adenine-treated animals experienced weight-loss, polyuria and polydipsia; however, these effects were significantly attenuated in adenine-treated Gunn rats."
"https://www.kegg.jp/entry/C00147","http://www.ihtsdo.org/SCT_28442001","Adenine-treated animals experienced weight-loss, polyuria and polydipsia; however, these effects were significantly attenuated in adenine-treated Gunn rats."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_414916001","Vitamin D3 Dose Requirement That Raises 25-Hydroxyvitamin D to Desirable Level in Overweight and Obese Elderly"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_154776002","Vitamin D3 Dose Requirement That Raises 25-Hydroxyvitamin D to Desirable Level in Overweight and Obese Elderly"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_190963004","Vitamin D3 Dose Requirement That Raises 25-Hydroxyvitamin D to Desirable Level in Overweight and Obese Elderly"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_414915002","Vitamin D3 Dose Requirement That Raises 25-Hydroxyvitamin D to Desirable Level in Overweight and Obese Elderly"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_5476005","Vitamin D3 Dose Requirement That Raises 25-Hydroxyvitamin D to Desirable Level in Overweight and Obese Elderly"
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_60481001","Potential of Medicinal Plants as Neuroprotective and Therapeutic Properties Against Amyloid-β-Related Toxicity, and Glutamate-Induced Excitotoxicity in Human Neural Cells"
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_75478009","Potential of Medicinal Plants as Neuroprotective and Therapeutic Properties Against Amyloid-β-Related Toxicity, and Glutamate-Induced Excitotoxicity in Human Neural Cells"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_129453003","Vitamin D3 (cholecalciferol) deficiency has been documented as a persistent problem among adults, children, and elderly persons in most of the countries."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_246199000","Vitamin D3 (cholecalciferol) deficiency has been documented as a persistent problem among adults, children, and elderly persons in most of the countries."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_260372006","Vitamin D3 (cholecalciferol) deficiency has been documented as a persistent problem among adults, children, and elderly persons in most of the countries."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_154722002","Vitamin D3 (cholecalciferol) deficiency has been documented as a persistent problem among adults, children, and elderly persons in most of the countries."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_154730001","Vitamin D3 (cholecalciferol) deficiency has been documented as a persistent problem among adults, children, and elderly persons in most of the countries."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_190595009","Vitamin D3 (cholecalciferol) deficiency has been documented as a persistent problem among adults, children, and elderly persons in most of the countries."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_190608007","Vitamin D3 (cholecalciferol) deficiency has been documented as a persistent problem among adults, children, and elderly persons in most of the countries."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_190678008","Vitamin D3 (cholecalciferol) deficiency has been documented as a persistent problem among adults, children, and elderly persons in most of the countries."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_238106006","Vitamin D3 (cholecalciferol) deficiency has been documented as a persistent problem among adults, children, and elderly persons in most of the countries."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_248325000","Vitamin D3 (cholecalciferol) deficiency has been documented as a persistent problem among adults, children, and elderly persons in most of the countries."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_2492009","Vitamin D3 (cholecalciferol) deficiency has been documented as a persistent problem among adults, children, and elderly persons in most of the countries."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_267409003","Vitamin D3 (cholecalciferol) deficiency has been documented as a persistent problem among adults, children, and elderly persons in most of the countries."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_267495004","Vitamin D3 (cholecalciferol) deficiency has been documented as a persistent problem among adults, children, and elderly persons in most of the countries."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_302868002","Vitamin D3 (cholecalciferol) deficiency has been documented as a persistent problem among adults, children, and elderly persons in most of the countries."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_47563007","Vitamin D3 (cholecalciferol) deficiency has been documented as a persistent problem among adults, children, and elderly persons in most of the countries."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_65404009","Vitamin D3 (cholecalciferol) deficiency has been documented as a persistent problem among adults, children, and elderly persons in most of the countries."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_70241007","Vitamin D3 (cholecalciferol) deficiency has been documented as a persistent problem among adults, children, and elderly persons in most of the countries."
"https://www.kegg.jp/entry/C00061","http://www.ihtsdo.org/SCT_61628006","Using sequence analysis and biochemical characterization, we found that NasN is an NADPH-dependent, diflavin-containing monomeric enzyme composed of a canonical molybdopterin cofactor-binding catalytic domain and an FMN-FAD/NAD-binding, electron-receiving/transferring domain, making it unique among all previously reported hetero-oligomeric NASs."
"https://www.kegg.jp/entry/C00061","http://www.ihtsdo.org/SCT_414819007","Using sequence analysis and biochemical characterization, we found that NasN is an NADPH-dependent, diflavin-containing monomeric enzyme composed of a canonical molybdopterin cofactor-binding catalytic domain and an FMN-FAD/NAD-binding, electron-receiving/transferring domain, making it unique among all previously reported hetero-oligomeric NASs."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_61628006","Using sequence analysis and biochemical characterization, we found that NasN is an NADPH-dependent, diflavin-containing monomeric enzyme composed of a canonical molybdopterin cofactor-binding catalytic domain and an FMN-FAD/NAD-binding, electron-receiving/transferring domain, making it unique among all previously reported hetero-oligomeric NASs."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_414819007","Using sequence analysis and biochemical characterization, we found that NasN is an NADPH-dependent, diflavin-containing monomeric enzyme composed of a canonical molybdopterin cofactor-binding catalytic domain and an FMN-FAD/NAD-binding, electron-receiving/transferring domain, making it unique among all previously reported hetero-oligomeric NASs."
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_154710000","Glutamate and aspartate alleviate testicular/epididymal oxidative stress by supporting antioxidant enzymes and immune defense systems in boars"
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_267485006","Glutamate and aspartate alleviate testicular/epididymal oxidative stress by supporting antioxidant enzymes and immune defense systems in boars"
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_73820008","Glutamate and aspartate alleviate testicular/epididymal oxidative stress by supporting antioxidant enzymes and immune defense systems in boars"
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_190565001","Glutamate and aspartate alleviate testicular/epididymal oxidative stress by supporting antioxidant enzymes and immune defense systems in boars"
"https://www.kegg.jp/entry/C00153","http://www.ihtsdo.org/SCT_54597004","Nicotinamide Ameliorates Dextran Sulfate Sodium-Induced Chronic Colitis in Mice through Its Anti-Inflammatory Properties and Modulates the Gut Microbiota"
"https://www.kegg.jp/entry/C00379","http://www.ihtsdo.org/SCT_263977005","Xylitol enhances synthesis of propionate in the colon via cross-feeding of gut microbiota"
"https://www.kegg.jp/entry/C00379","http://www.ihtsdo.org/SCT_71854001","Xylitol enhances synthesis of propionate in the colon via cross-feeding of gut microbiota"
"https://www.kegg.jp/entry/C00379","http://www.ihtsdo.org/SCT_128524007","Xylitol enhances synthesis of propionate in the colon via cross-feeding of gut microbiota"
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_414916001","Dietary Supplementation with Glycine Enhances Intestinal Mucosal Integrity and Ameliorates Inflammation in C57BL/6J Mice with High-Fat Diet-Induced Obesity"
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_154776002","Dietary Supplementation with Glycine Enhances Intestinal Mucosal Integrity and Ameliorates Inflammation in C57BL/6J Mice with High-Fat Diet-Induced Obesity"
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_190963004","Dietary Supplementation with Glycine Enhances Intestinal Mucosal Integrity and Ameliorates Inflammation in C57BL/6J Mice with High-Fat Diet-Induced Obesity"
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_414915002","Dietary Supplementation with Glycine Enhances Intestinal Mucosal Integrity and Ameliorates Inflammation in C57BL/6J Mice with High-Fat Diet-Induced Obesity"
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_5476005","Dietary Supplementation with Glycine Enhances Intestinal Mucosal Integrity and Ameliorates Inflammation in C57BL/6J Mice with High-Fat Diet-Induced Obesity"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_156106005","Results: Homocysteine and MDA levels were significantly different between women with preeclampsia and normal pregnancies (&gt;i&lt;p&gt;/i&lt;-value &lt;0.001)."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_156109003","Results: Homocysteine and MDA levels were significantly different between women with preeclampsia and normal pregnancies (&gt;i&lt;p&gt;/i&lt;-value &lt;0.001)."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_198972006","Results: Homocysteine and MDA levels were significantly different between women with preeclampsia and normal pregnancies (&gt;i&lt;p&gt;/i&lt;-value &lt;0.001)."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_198979002","Results: Homocysteine and MDA levels were significantly different between women with preeclampsia and normal pregnancies (&gt;i&lt;p&gt;/i&lt;-value &lt;0.001)."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_199011002","Results: Homocysteine and MDA levels were significantly different between women with preeclampsia and normal pregnancies (&gt;i&lt;p&gt;/i&lt;-value &lt;0.001)."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_267306006","Results: Homocysteine and MDA levels were significantly different between women with preeclampsia and normal pregnancies (&gt;i&lt;p&gt;/i&lt;-value &lt;0.001)."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_288201007","Results: Homocysteine and MDA levels were significantly different between women with preeclampsia and normal pregnancies (&gt;i&lt;p&gt;/i&lt;-value &lt;0.001)."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_398254007","Results: Homocysteine and MDA levels were significantly different between women with preeclampsia and normal pregnancies (&gt;i&lt;p&gt;/i&lt;-value &lt;0.001)."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_6758009","Results: Homocysteine and MDA levels were significantly different between women with preeclampsia and normal pregnancies (&gt;i&lt;p&gt;/i&lt;-value &lt;0.001)."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_46764007","Results: Homocysteine and MDA levels were significantly different between women with preeclampsia and normal pregnancies (&gt;i&lt;p&gt;/i&lt;-value &lt;0.001)."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_15394000","Results: Homocysteine and MDA levels were significantly different between women with preeclampsia and normal pregnancies (&gt;i&lt;p&gt;/i&lt;-value &lt;0.001)."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_237280005","Results: Homocysteine and MDA levels were significantly different between women with preeclampsia and normal pregnancies (&gt;i&lt;p&gt;/i&lt;-value &lt;0.001)."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_124886009","Vitamin D3 supplementation should be considered in IBS-D patients who suffer from vitamin D deficiency and/or insufficiency."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_154728003","Vitamin D3 supplementation should be considered in IBS-D patients who suffer from vitamin D deficiency and/or insufficiency."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_190639009","Vitamin D3 supplementation should be considered in IBS-D patients who suffer from vitamin D deficiency and/or insufficiency."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_190649007","Vitamin D3 supplementation should be considered in IBS-D patients who suffer from vitamin D deficiency and/or insufficiency."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_34713006","Vitamin D3 supplementation should be considered in IBS-D patients who suffer from vitamin D deficiency and/or insufficiency."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_131143000","Various nutritional signals are transduced by two epigenetic pathways: NAD-dependent sirtuin Sirt1 (NAD&gt;sup&lt;+&gt;/sup&lt;-Sirt1) deacetylase and flavin adenine dinucleotide-dependent lysine-specific demethylase 1 (FAD-LSD1)."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_189759009","Various nutritional signals are transduced by two epigenetic pathways: NAD-dependent sirtuin Sirt1 (NAD&gt;sup&lt;+&gt;/sup&lt;-Sirt1) deacetylase and flavin adenine dinucleotide-dependent lysine-specific demethylase 1 (FAD-LSD1)."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_254818000","Various nutritional signals are transduced by two epigenetic pathways: NAD-dependent sirtuin Sirt1 (NAD&gt;sup&lt;+&gt;/sup&lt;-Sirt1) deacetylase and flavin adenine dinucleotide-dependent lysine-specific demethylase 1 (FAD-LSD1)."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_61814002","Various nutritional signals are transduced by two epigenetic pathways: NAD-dependent sirtuin Sirt1 (NAD&gt;sup&lt;+&gt;/sup&lt;-Sirt1) deacetylase and flavin adenine dinucleotide-dependent lysine-specific demethylase 1 (FAD-LSD1)."
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_131143000","Distinct Roles of the NAD +-Sirt1 and FAD-LSD1 Pathways in Metabolic Response and Tissue Development"
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_189759009","Distinct Roles of the NAD +-Sirt1 and FAD-LSD1 Pathways in Metabolic Response and Tissue Development"
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_254818000","Distinct Roles of the NAD +-Sirt1 and FAD-LSD1 Pathways in Metabolic Response and Tissue Development"
"https://www.kegg.jp/entry/C00016","http://www.ihtsdo.org/SCT_61814002","Distinct Roles of the NAD +-Sirt1 and FAD-LSD1 Pathways in Metabolic Response and Tissue Development"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_154671004","Vitamin D3 supplementation improves serum SFRP5 and Wnt5a levels in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_191044006","Vitamin D3 supplementation improves serum SFRP5 and Wnt5a levels in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_267467004","Vitamin D3 supplementation improves serum SFRP5 and Wnt5a levels in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_73211009","Vitamin D3 supplementation improves serum SFRP5 and Wnt5a levels in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_419503008","Homocysteine-lowering exercise effect is greater in hyperhomocysteinemic people living with HIV: a randomized clinical trial"
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_238126005","Introduction: Thiamine (vitamin B1) deficiency remains a concern in Cambodia where women with low thiamine intake produce thiamine-poor milk, putting their breastfed infants at risk of impaired cognitive development and potentially fatal infantile beriberi."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_129453003","Introduction: Thiamine (vitamin B1) deficiency remains a concern in Cambodia where women with low thiamine intake produce thiamine-poor milk, putting their breastfed infants at risk of impaired cognitive development and potentially fatal infantile beriberi."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_246199000","Introduction: Thiamine (vitamin B1) deficiency remains a concern in Cambodia where women with low thiamine intake produce thiamine-poor milk, putting their breastfed infants at risk of impaired cognitive development and potentially fatal infantile beriberi."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_260372006","Introduction: Thiamine (vitamin B1) deficiency remains a concern in Cambodia where women with low thiamine intake produce thiamine-poor milk, putting their breastfed infants at risk of impaired cognitive development and potentially fatal infantile beriberi."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_154722002","Introduction: Thiamine (vitamin B1) deficiency remains a concern in Cambodia where women with low thiamine intake produce thiamine-poor milk, putting their breastfed infants at risk of impaired cognitive development and potentially fatal infantile beriberi."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_154730001","Introduction: Thiamine (vitamin B1) deficiency remains a concern in Cambodia where women with low thiamine intake produce thiamine-poor milk, putting their breastfed infants at risk of impaired cognitive development and potentially fatal infantile beriberi."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_190595009","Introduction: Thiamine (vitamin B1) deficiency remains a concern in Cambodia where women with low thiamine intake produce thiamine-poor milk, putting their breastfed infants at risk of impaired cognitive development and potentially fatal infantile beriberi."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_190608007","Introduction: Thiamine (vitamin B1) deficiency remains a concern in Cambodia where women with low thiamine intake produce thiamine-poor milk, putting their breastfed infants at risk of impaired cognitive development and potentially fatal infantile beriberi."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_190678008","Introduction: Thiamine (vitamin B1) deficiency remains a concern in Cambodia where women with low thiamine intake produce thiamine-poor milk, putting their breastfed infants at risk of impaired cognitive development and potentially fatal infantile beriberi."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_238106006","Introduction: Thiamine (vitamin B1) deficiency remains a concern in Cambodia where women with low thiamine intake produce thiamine-poor milk, putting their breastfed infants at risk of impaired cognitive development and potentially fatal infantile beriberi."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_248325000","Introduction: Thiamine (vitamin B1) deficiency remains a concern in Cambodia where women with low thiamine intake produce thiamine-poor milk, putting their breastfed infants at risk of impaired cognitive development and potentially fatal infantile beriberi."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_2492009","Introduction: Thiamine (vitamin B1) deficiency remains a concern in Cambodia where women with low thiamine intake produce thiamine-poor milk, putting their breastfed infants at risk of impaired cognitive development and potentially fatal infantile beriberi."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_267409003","Introduction: Thiamine (vitamin B1) deficiency remains a concern in Cambodia where women with low thiamine intake produce thiamine-poor milk, putting their breastfed infants at risk of impaired cognitive development and potentially fatal infantile beriberi."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_267495004","Introduction: Thiamine (vitamin B1) deficiency remains a concern in Cambodia where women with low thiamine intake produce thiamine-poor milk, putting their breastfed infants at risk of impaired cognitive development and potentially fatal infantile beriberi."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_302868002","Introduction: Thiamine (vitamin B1) deficiency remains a concern in Cambodia where women with low thiamine intake produce thiamine-poor milk, putting their breastfed infants at risk of impaired cognitive development and potentially fatal infantile beriberi."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_47563007","Introduction: Thiamine (vitamin B1) deficiency remains a concern in Cambodia where women with low thiamine intake produce thiamine-poor milk, putting their breastfed infants at risk of impaired cognitive development and potentially fatal infantile beriberi."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_65404009","Introduction: Thiamine (vitamin B1) deficiency remains a concern in Cambodia where women with low thiamine intake produce thiamine-poor milk, putting their breastfed infants at risk of impaired cognitive development and potentially fatal infantile beriberi."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_70241007","Introduction: Thiamine (vitamin B1) deficiency remains a concern in Cambodia where women with low thiamine intake produce thiamine-poor milk, putting their breastfed infants at risk of impaired cognitive development and potentially fatal infantile beriberi."
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_37796009","Vitamin D3 might improve headache characteristics and protect against inflammation in migraine: a randomized clinical trial"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_155046006","Vitamin D3 might improve headache characteristics and protect against inflammation in migraine: a randomized clinical trial"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_155048007","Vitamin D3 might improve headache characteristics and protect against inflammation in migraine: a randomized clinical trial"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_267699004","Vitamin D3 might improve headache characteristics and protect against inflammation in migraine: a randomized clinical trial"
"https://www.kegg.jp/entry/C05443","http://www.ihtsdo.org/SCT_193041007","Vitamin D3 might improve headache characteristics and protect against inflammation in migraine: a randomized clinical trial"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_127072000","Pectin has shown immunomodulatory effects on allergies, although the underlying mechanisms still need to be elucidated."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_157754004","Pectin has shown immunomodulatory effects on allergies, although the underlying mechanisms still need to be elucidated."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_157758001","Pectin has shown immunomodulatory effects on allergies, although the underlying mechanisms still need to be elucidated."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_212998004","Pectin has shown immunomodulatory effects on allergies, although the underlying mechanisms still need to be elucidated."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_212999007","Pectin has shown immunomodulatory effects on allergies, although the underlying mechanisms still need to be elucidated."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_21957007","Pectin has shown immunomodulatory effects on allergies, although the underlying mechanisms still need to be elucidated."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_257550005","Pectin has shown immunomodulatory effects on allergies, although the underlying mechanisms still need to be elucidated."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_269432007","Pectin has shown immunomodulatory effects on allergies, although the underlying mechanisms still need to be elucidated."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_274211000","Pectin has shown immunomodulatory effects on allergies, although the underlying mechanisms still need to be elucidated."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_282092005","Pectin has shown immunomodulatory effects on allergies, although the underlying mechanisms still need to be elucidated."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_418168000","Pectin has shown immunomodulatory effects on allergies, although the underlying mechanisms still need to be elucidated."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_418634005","Pectin has shown immunomodulatory effects on allergies, although the underlying mechanisms still need to be elucidated."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_91232002","Pectin has shown immunomodulatory effects on allergies, although the underlying mechanisms still need to be elucidated."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_421961002","Pectin has shown immunomodulatory effects on allergies, although the underlying mechanisms still need to be elucidated."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_106190000","Pectin has shown immunomodulatory effects on allergies, although the underlying mechanisms still need to be elucidated."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_269284003","Pectin has shown immunomodulatory effects on allergies, although the underlying mechanisms still need to be elucidated."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_418925002","Pectin has shown immunomodulatory effects on allergies, although the underlying mechanisms still need to be elucidated."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_421668005","Pectin has shown immunomodulatory effects on allergies, although the underlying mechanisms still need to be elucidated."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_127072000","The Dietary Fiber Pectin: Health Benefits and Potential for the Treatment of Allergies by Modulation of Gut Microbiota"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_157754004","The Dietary Fiber Pectin: Health Benefits and Potential for the Treatment of Allergies by Modulation of Gut Microbiota"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_157758001","The Dietary Fiber Pectin: Health Benefits and Potential for the Treatment of Allergies by Modulation of Gut Microbiota"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_212998004","The Dietary Fiber Pectin: Health Benefits and Potential for the Treatment of Allergies by Modulation of Gut Microbiota"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_212999007","The Dietary Fiber Pectin: Health Benefits and Potential for the Treatment of Allergies by Modulation of Gut Microbiota"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_21957007","The Dietary Fiber Pectin: Health Benefits and Potential for the Treatment of Allergies by Modulation of Gut Microbiota"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_257550005","The Dietary Fiber Pectin: Health Benefits and Potential for the Treatment of Allergies by Modulation of Gut Microbiota"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_269432007","The Dietary Fiber Pectin: Health Benefits and Potential for the Treatment of Allergies by Modulation of Gut Microbiota"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_274211000","The Dietary Fiber Pectin: Health Benefits and Potential for the Treatment of Allergies by Modulation of Gut Microbiota"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_282092005","The Dietary Fiber Pectin: Health Benefits and Potential for the Treatment of Allergies by Modulation of Gut Microbiota"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_418168000","The Dietary Fiber Pectin: Health Benefits and Potential for the Treatment of Allergies by Modulation of Gut Microbiota"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_418634005","The Dietary Fiber Pectin: Health Benefits and Potential for the Treatment of Allergies by Modulation of Gut Microbiota"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_91232002","The Dietary Fiber Pectin: Health Benefits and Potential for the Treatment of Allergies by Modulation of Gut Microbiota"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_421961002","The Dietary Fiber Pectin: Health Benefits and Potential for the Treatment of Allergies by Modulation of Gut Microbiota"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_106190000","The Dietary Fiber Pectin: Health Benefits and Potential for the Treatment of Allergies by Modulation of Gut Microbiota"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_269284003","The Dietary Fiber Pectin: Health Benefits and Potential for the Treatment of Allergies by Modulation of Gut Microbiota"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_418925002","The Dietary Fiber Pectin: Health Benefits and Potential for the Treatment of Allergies by Modulation of Gut Microbiota"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_421668005","The Dietary Fiber Pectin: Health Benefits and Potential for the Treatment of Allergies by Modulation of Gut Microbiota"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_154634001","Results: Sucrose consumption was associated with a higher odds and fiber consumption with a lower odds of ADT after accounting for age, race/ethnicity, body mass index, and tumor characteristics (odds ratio [OR] (95% confidence interval [CI]) 5.68 (1.71, 18.9) for 3rd vs. 1st sucrose tertile and 0.88 (0.81, 0.96) per gram of fiber/day, respectively)."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_154645003","Results: Sucrose consumption was associated with a higher odds and fiber consumption with a lower odds of ADT after accounting for age, race/ethnicity, body mass index, and tumor characteristics (odds ratio [OR] (95% confidence interval [CI]) 5.68 (1.71, 18.9) for 3rd vs. 1st sucrose tertile and 0.88 (0.81, 0.96) per gram of fiber/day, respectively)."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_154646002","Results: Sucrose consumption was associated with a higher odds and fiber consumption with a lower odds of ADT after accounting for age, race/ethnicity, body mass index, and tumor characteristics (odds ratio [OR] (95% confidence interval [CI]) 5.68 (1.71, 18.9) for 3rd vs. 1st sucrose tertile and 0.88 (0.81, 0.96) per gram of fiber/day, respectively)."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_190230000","Results: Sucrose consumption was associated with a higher odds and fiber consumption with a lower odds of ADT after accounting for age, race/ethnicity, body mass index, and tumor characteristics (odds ratio [OR] (95% confidence interval [CI]) 5.68 (1.71, 18.9) for 3rd vs. 1st sucrose tertile and 0.88 (0.81, 0.96) per gram of fiber/day, respectively)."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_187597000","Results: Sucrose consumption was associated with a higher odds and fiber consumption with a lower odds of ADT after accounting for age, race/ethnicity, body mass index, and tumor characteristics (odds ratio [OR] (95% confidence interval [CI]) 5.68 (1.71, 18.9) for 3rd vs. 1st sucrose tertile and 0.88 (0.81, 0.96) per gram of fiber/day, respectively)."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_108369006","Results: Sucrose consumption was associated with a higher odds and fiber consumption with a lower odds of ADT after accounting for age, race/ethnicity, body mass index, and tumor characteristics (odds ratio [OR] (95% confidence interval [CI]) 5.68 (1.71, 18.9) for 3rd vs. 1st sucrose tertile and 0.88 (0.81, 0.96) per gram of fiber/day, respectively)."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_189542002","Results: Sucrose consumption was associated with a higher odds and fiber consumption with a lower odds of ADT after accounting for age, race/ethnicity, body mass index, and tumor characteristics (odds ratio [OR] (95% confidence interval [CI]) 5.68 (1.71, 18.9) for 3rd vs. 1st sucrose tertile and 0.88 (0.81, 0.96) per gram of fiber/day, respectively)."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_86251006","Results: Sucrose consumption was associated with a higher odds and fiber consumption with a lower odds of ADT after accounting for age, race/ethnicity, body mass index, and tumor characteristics (odds ratio [OR] (95% confidence interval [CI]) 5.68 (1.71, 18.9) for 3rd vs. 1st sucrose tertile and 0.88 (0.81, 0.96) per gram of fiber/day, respectively)."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_154671004","Conclusion: L-Carnitine could be a valuable dietary supplement in patients with type II diabetes who follow a Mediterranean diet and are under recommended treatment."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_191044006","Conclusion: L-Carnitine could be a valuable dietary supplement in patients with type II diabetes who follow a Mediterranean diet and are under recommended treatment."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_267467004","Conclusion: L-Carnitine could be a valuable dietary supplement in patients with type II diabetes who follow a Mediterranean diet and are under recommended treatment."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_73211009","Conclusion: L-Carnitine could be a valuable dietary supplement in patients with type II diabetes who follow a Mediterranean diet and are under recommended treatment."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_157334002","Glycine supplementation has been reported to alleviate lipopolysaccharide (LPS)-induced lung injury in mice."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_233809004","Glycine supplementation has been reported to alleviate lipopolysaccharide (LPS)-induced lung injury in mice."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_314401006","Glycine supplementation has been reported to alleviate lipopolysaccharide (LPS)-induced lung injury in mice."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_53544003","Glycine supplementation has been reported to alleviate lipopolysaccharide (LPS)-induced lung injury in mice."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_316358009","Glycine supplementation has been reported to alleviate lipopolysaccharide (LPS)-induced lung injury in mice."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_315345002","Glycine Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Regulating NLRP3 Inflammasome and NRF2 Signaling"
"https://www.kegg.jp/entry/C00116","http://www.ihtsdo.org/SCT_156726002","Valorization of Crude Glycerol, Residue Deriving from Biodiesel- Production Process, with the Use of Wild-type New Isolated Yarrowia lipolytica Strains: Production of Metabolites with Pharmaceutical and Biotechnological Interest"
"https://www.kegg.jp/entry/C00116","http://www.ihtsdo.org/SCT_157257005","Valorization of Crude Glycerol, Residue Deriving from Biodiesel- Production Process, with the Use of Wild-type New Isolated Yarrowia lipolytica Strains: Production of Metabolites with Pharmaceutical and Biotechnological Interest"
"https://www.kegg.jp/entry/C00116","http://www.ihtsdo.org/SCT_203094001","Valorization of Crude Glycerol, Residue Deriving from Biodiesel- Production Process, with the Use of Wild-type New Isolated Yarrowia lipolytica Strains: Production of Metabolites with Pharmaceutical and Biotechnological Interest"
"https://www.kegg.jp/entry/C00116","http://www.ihtsdo.org/SCT_269324003","Valorization of Crude Glycerol, Residue Deriving from Biodiesel- Production Process, with the Use of Wild-type New Isolated Yarrowia lipolytica Strains: Production of Metabolites with Pharmaceutical and Biotechnological Interest"
"https://www.kegg.jp/entry/C00116","http://www.ihtsdo.org/SCT_367127009","Valorization of Crude Glycerol, Residue Deriving from Biodiesel- Production Process, with the Use of Wild-type New Isolated Yarrowia lipolytica Strains: Production of Metabolites with Pharmaceutical and Biotechnological Interest"
"https://www.kegg.jp/entry/C00116","http://www.ihtsdo.org/SCT_48532005","Valorization of Crude Glycerol, Residue Deriving from Biodiesel- Production Process, with the Use of Wild-type New Isolated Yarrowia lipolytica Strains: Production of Metabolites with Pharmaceutical and Biotechnological Interest"
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_64572001","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_56267009","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_154850006","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_192165000","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_268613002","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_192171006","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_429998004","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_419503008","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_129453003","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_246199000","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_260372006","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_154722002","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_154730001","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_190595009","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_190608007","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_190678008","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_238106006","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_248325000","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_2492009","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_267409003","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_267495004","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_302868002","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_47563007","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_65404009","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_70241007","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_155388006","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_266312006","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_62914000","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_155412002","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_195595007","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_195249004","Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia."
"https://www.kegg.jp/entry/C00718","http://www.ihtsdo.org/SCT_2911006","Amylose content and starch crystallinity in corn decreased significantly (&gt;i&lt;p&gt;/i&lt; &lt; 0.05) at an irradiation dose higher than 20 kGy."
"https://www.kegg.jp/entry/C00718","http://www.ihtsdo.org/SCT_46014006","Amylose content and starch crystallinity in corn decreased significantly (&gt;i&lt;p&gt;/i&lt; &lt; 0.05) at an irradiation dose higher than 20 kGy."
"https://www.kegg.jp/entry/C00718","http://www.ihtsdo.org/SCT_201038005","Amylose content and starch crystallinity in corn decreased significantly (&gt;i&lt;p&gt;/i&lt; &lt; 0.05) at an irradiation dose higher than 20 kGy."
"https://www.kegg.jp/entry/C00718","http://www.ihtsdo.org/SCT_201039002","Amylose content and starch crystallinity in corn decreased significantly (&gt;i&lt;p&gt;/i&lt; &lt; 0.05) at an irradiation dose higher than 20 kGy."
"https://www.kegg.jp/entry/C00718","http://www.ihtsdo.org/SCT_2447002","Amylose content and starch crystallinity in corn decreased significantly (&gt;i&lt;p&gt;/i&lt; &lt; 0.05) at an irradiation dose higher than 20 kGy."
"https://www.kegg.jp/entry/C00718","http://www.ihtsdo.org/SCT_412357001","Amylose content and starch crystallinity in corn decreased significantly (&gt;i&lt;p&gt;/i&lt; &lt; 0.05) at an irradiation dose higher than 20 kGy."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_192824002","Homocysteine effects on brain atrophy rate were modified by iron and cysteine."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_278849000","Homocysteine effects on brain atrophy rate were modified by iron and cysteine."
"https://www.kegg.jp/entry/C01673","http://www.ihtsdo.org/SCT_363510005","Calcitriol Suppresses Warburg Effect and Cell Growth in Human Colorectal Cancer Cells"
"https://www.kegg.jp/entry/C01673","http://www.ihtsdo.org/SCT_93854002","Calcitriol Suppresses Warburg Effect and Cell Growth in Human Colorectal Cancer Cells"
"https://www.kegg.jp/entry/C00369","http://www.ihtsdo.org/SCT_22199006","Starch plays a crucial role in the stabilization and dispersion of Se NPs, as noticed from the TEM and EDS investigations."
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_155375008","High Plasma Glutamate and a Low Glutamine-to-Glutamate Ratio Are Associated with Increased Risk of Heart Failure but Not Atrial Fibrillation in the Prevención con Dieta Mediterránea (PREDIMED) Study"
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_266308000","High Plasma Glutamate and a Low Glutamine-to-Glutamate Ratio Are Associated with Increased Risk of Heart Failure but Not Atrial Fibrillation in the Prevención con Dieta Mediterránea (PREDIMED) Study"
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_84114007","High Plasma Glutamate and a Low Glutamine-to-Glutamate Ratio Are Associated with Increased Risk of Heart Failure but Not Atrial Fibrillation in the Prevención con Dieta Mediterránea (PREDIMED) Study"
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_155374007","High Plasma Glutamate and a Low Glutamine-to-Glutamate Ratio Are Associated with Increased Risk of Heart Failure but Not Atrial Fibrillation in the Prevención con Dieta Mediterránea (PREDIMED) Study"
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_155377000","High Plasma Glutamate and a Low Glutamine-to-Glutamate Ratio Are Associated with Increased Risk of Heart Failure but Not Atrial Fibrillation in the Prevención con Dieta Mediterránea (PREDIMED) Study"
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_195117009","High Plasma Glutamate and a Low Glutamine-to-Glutamate Ratio Are Associated with Increased Risk of Heart Failure but Not Atrial Fibrillation in the Prevención con Dieta Mediterránea (PREDIMED) Study"
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_266248006","High Plasma Glutamate and a Low Glutamine-to-Glutamate Ratio Are Associated with Increased Risk of Heart Failure but Not Atrial Fibrillation in the Prevención con Dieta Mediterránea (PREDIMED) Study"
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_195108009","High Plasma Glutamate and a Low Glutamine-to-Glutamate Ratio Are Associated with Increased Risk of Heart Failure but Not Atrial Fibrillation in the Prevención con Dieta Mediterránea (PREDIMED) Study"
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_42343007","High Plasma Glutamate and a Low Glutamine-to-Glutamate Ratio Are Associated with Increased Risk of Heart Failure but Not Atrial Fibrillation in the Prevención con Dieta Mediterránea (PREDIMED) Study"
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_49436004","High Plasma Glutamate and a Low Glutamine-to-Glutamate Ratio Are Associated with Increased Risk of Heart Failure but Not Atrial Fibrillation in the Prevención con Dieta Mediterránea (PREDIMED) Study"
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_155364009","High Plasma Glutamate and a Low Glutamine-to-Glutamate Ratio Are Associated with Increased Risk of Heart Failure but Not Atrial Fibrillation in the Prevención con Dieta Mediterránea (PREDIMED) Study"
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_266306001","High Plasma Glutamate and a Low Glutamine-to-Glutamate Ratio Are Associated with Increased Risk of Heart Failure but Not Atrial Fibrillation in the Prevención con Dieta Mediterránea (PREDIMED) Study"
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_164889003","High Plasma Glutamate and a Low Glutamine-to-Glutamate Ratio Are Associated with Increased Risk of Heart Failure but Not Atrial Fibrillation in the Prevención con Dieta Mediterránea (PREDIMED) Study"
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_142049000","High Plasma Glutamate and a Low Glutamine-to-Glutamate Ratio Are Associated with Increased Risk of Heart Failure but Not Atrial Fibrillation in the Prevención con Dieta Mediterránea (PREDIMED) Study"
"https://www.kegg.jp/entry/C00255","http://www.ihtsdo.org/SCT_61261009","Background: Riboflavin is required for erythropoiesis, which is increased in people with hemoglobinopathies due to increased hemolysis and erythrocyte turnover."
"https://www.kegg.jp/entry/C00255","http://www.ihtsdo.org/SCT_191231008","Background: Riboflavin is required for erythropoiesis, which is increased in people with hemoglobinopathies due to increased hemolysis and erythrocyte turnover."
"https://www.kegg.jp/entry/C00255","http://www.ihtsdo.org/SCT_191416001","Background: Riboflavin is required for erythropoiesis, which is increased in people with hemoglobinopathies due to increased hemolysis and erythrocyte turnover."
"https://www.kegg.jp/entry/C00255","http://www.ihtsdo.org/SCT_80141007","Background: Riboflavin is required for erythropoiesis, which is increased in people with hemoglobinopathies due to increased hemolysis and erythrocyte turnover."
"https://www.kegg.jp/entry/C00255","http://www.ihtsdo.org/SCT_154794008","Background: Riboflavin is required for erythropoiesis, which is increased in people with hemoglobinopathies due to increased hemolysis and erythrocyte turnover."
"https://www.kegg.jp/entry/C00255","http://www.ihtsdo.org/SCT_267556002","Background: Riboflavin is required for erythropoiesis, which is increased in people with hemoglobinopathies due to increased hemolysis and erythrocyte turnover."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_154963001","Results: Homocysteine level was higher in subjects with depression in comparison with healthy controls (weight mean difference = 2.53 µmol/L, 95% confidence interval: 1.77, 3.30), and the depression diagnostic tool was a source of heterogeneity."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_192372006","Results: Homocysteine level was higher in subjects with depression in comparison with healthy controls (weight mean difference = 2.53 µmol/L, 95% confidence interval: 1.77, 3.30), and the depression diagnostic tool was a source of heterogeneity."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_307537002","Results: Homocysteine level was higher in subjects with depression in comparison with healthy controls (weight mean difference = 2.53 µmol/L, 95% confidence interval: 1.77, 3.30), and the depression diagnostic tool was a source of heterogeneity."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_41006004","Results: Homocysteine level was higher in subjects with depression in comparison with healthy controls (weight mean difference = 2.53 µmol/L, 95% confidence interval: 1.77, 3.30), and the depression diagnostic tool was a source of heterogeneity."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_21061000119107","Results: Homocysteine level was higher in subjects with depression in comparison with healthy controls (weight mean difference = 2.53 µmol/L, 95% confidence interval: 1.77, 3.30), and the depression diagnostic tool was a source of heterogeneity."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_35489007","Results: Homocysteine level was higher in subjects with depression in comparison with healthy controls (weight mean difference = 2.53 µmol/L, 95% confidence interval: 1.77, 3.30), and the depression diagnostic tool was a source of heterogeneity."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_78667006","Results: Homocysteine level was higher in subjects with depression in comparison with healthy controls (weight mean difference = 2.53 µmol/L, 95% confidence interval: 1.77, 3.30), and the depression diagnostic tool was a source of heterogeneity."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_255339005","Results: Homocysteine level was higher in subjects with depression in comparison with healthy controls (weight mean difference = 2.53 µmol/L, 95% confidence interval: 1.77, 3.30), and the depression diagnostic tool was a source of heterogeneity."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_154963001","Homocysteine level was significantly higher in subjects with depression in studies that used Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV), Geriatric Depression Scale (GDS), Zung Self-Rating Depression Scale (ZDRS) and Beck Depression Index II (BDI-II) as depression diagnostic tools."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_192372006","Homocysteine level was significantly higher in subjects with depression in studies that used Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV), Geriatric Depression Scale (GDS), Zung Self-Rating Depression Scale (ZDRS) and Beck Depression Index II (BDI-II) as depression diagnostic tools."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_307537002","Homocysteine level was significantly higher in subjects with depression in studies that used Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV), Geriatric Depression Scale (GDS), Zung Self-Rating Depression Scale (ZDRS) and Beck Depression Index II (BDI-II) as depression diagnostic tools."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_41006004","Homocysteine level was significantly higher in subjects with depression in studies that used Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV), Geriatric Depression Scale (GDS), Zung Self-Rating Depression Scale (ZDRS) and Beck Depression Index II (BDI-II) as depression diagnostic tools."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_21061000119107","Homocysteine level was significantly higher in subjects with depression in studies that used Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV), Geriatric Depression Scale (GDS), Zung Self-Rating Depression Scale (ZDRS) and Beck Depression Index II (BDI-II) as depression diagnostic tools."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_35489007","Homocysteine level was significantly higher in subjects with depression in studies that used Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV), Geriatric Depression Scale (GDS), Zung Self-Rating Depression Scale (ZDRS) and Beck Depression Index II (BDI-II) as depression diagnostic tools."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_78667006","Homocysteine level was significantly higher in subjects with depression in studies that used Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV), Geriatric Depression Scale (GDS), Zung Self-Rating Depression Scale (ZDRS) and Beck Depression Index II (BDI-II) as depression diagnostic tools."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_255339005","Homocysteine level was significantly higher in subjects with depression in studies that used Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV), Geriatric Depression Scale (GDS), Zung Self-Rating Depression Scale (ZDRS) and Beck Depression Index II (BDI-II) as depression diagnostic tools."
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_414916001","Glutamate interactions with obesity, insulin resistance, cognition and gut microbiota composition"
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_154776002","Glutamate interactions with obesity, insulin resistance, cognition and gut microbiota composition"
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_190963004","Glutamate interactions with obesity, insulin resistance, cognition and gut microbiota composition"
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_414915002","Glutamate interactions with obesity, insulin resistance, cognition and gut microbiota composition"
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_5476005","Glutamate interactions with obesity, insulin resistance, cognition and gut microbiota composition"
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_139335002","Background and objectives: Pectin-containing liquid enteral nutrition (PCLEN) contains pectin, which becomes solid in the stomach and therefore mitigates vomiting and diarrhea."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_139337005","Background and objectives: Pectin-containing liquid enteral nutrition (PCLEN) contains pectin, which becomes solid in the stomach and therefore mitigates vomiting and diarrhea."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_139342002","Background and objectives: Pectin-containing liquid enteral nutrition (PCLEN) contains pectin, which becomes solid in the stomach and therefore mitigates vomiting and diarrhea."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_15387003","Background and objectives: Pectin-containing liquid enteral nutrition (PCLEN) contains pectin, which becomes solid in the stomach and therefore mitigates vomiting and diarrhea."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_158422007","Background and objectives: Pectin-containing liquid enteral nutrition (PCLEN) contains pectin, which becomes solid in the stomach and therefore mitigates vomiting and diarrhea."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_158423002","Background and objectives: Pectin-containing liquid enteral nutrition (PCLEN) contains pectin, which becomes solid in the stomach and therefore mitigates vomiting and diarrhea."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_162061001","Background and objectives: Pectin-containing liquid enteral nutrition (PCLEN) contains pectin, which becomes solid in the stomach and therefore mitigates vomiting and diarrhea."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_162063003","Background and objectives: Pectin-containing liquid enteral nutrition (PCLEN) contains pectin, which becomes solid in the stomach and therefore mitigates vomiting and diarrhea."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_162067002","Background and objectives: Pectin-containing liquid enteral nutrition (PCLEN) contains pectin, which becomes solid in the stomach and therefore mitigates vomiting and diarrhea."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_207112000","Background and objectives: Pectin-containing liquid enteral nutrition (PCLEN) contains pectin, which becomes solid in the stomach and therefore mitigates vomiting and diarrhea."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_207113005","Background and objectives: Pectin-containing liquid enteral nutrition (PCLEN) contains pectin, which becomes solid in the stomach and therefore mitigates vomiting and diarrhea."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_236082001","Background and objectives: Pectin-containing liquid enteral nutrition (PCLEN) contains pectin, which becomes solid in the stomach and therefore mitigates vomiting and diarrhea."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_249497008","Background and objectives: Pectin-containing liquid enteral nutrition (PCLEN) contains pectin, which becomes solid in the stomach and therefore mitigates vomiting and diarrhea."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_300359004","Background and objectives: Pectin-containing liquid enteral nutrition (PCLEN) contains pectin, which becomes solid in the stomach and therefore mitigates vomiting and diarrhea."
"https://www.kegg.jp/entry/C00714","http://www.ihtsdo.org/SCT_422400008","Background and objectives: Pectin-containing liquid enteral nutrition (PCLEN) contains pectin, which becomes solid in the stomach and therefore mitigates vomiting and diarrhea."
"https://www.kegg.jp/entry/C00072","http://www.ihtsdo.org/SCT_339947000","Ascorbate status was higher in women than in men, and exercising patients had higher levels than sedentary patients."
"https://www.kegg.jp/entry/C00072","http://www.ihtsdo.org/SCT_190566000","Ascorbate status was higher in women than in men, and exercising patients had higher levels than sedentary patients."
"https://www.kegg.jp/entry/C00072","http://www.ihtsdo.org/SCT_46724008","Ascorbate status was higher in women than in men, and exercising patients had higher levels than sedentary patients."
"https://www.kegg.jp/entry/C00072","http://www.ihtsdo.org/SCT_60549007","Ascorbate status was higher in women than in men, and exercising patients had higher levels than sedentary patients."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_448710000","Leucine and branched-chain amino acid metabolism contribute to the growth of bone sarcomas by regulating AMPK and mTORC1 signaling"
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_118940003","Thiamine can deplete rapidly in CD and UC, which can lead to Wernicke's encephalopathy (WE), is an acute neurologic disorder."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_286946008","Thiamine can deplete rapidly in CD and UC, which can lead to Wernicke's encephalopathy (WE), is an acute neurologic disorder."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_154981003","Thiamine can deplete rapidly in CD and UC, which can lead to Wernicke's encephalopathy (WE), is an acute neurologic disorder."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_155262005","Thiamine can deplete rapidly in CD and UC, which can lead to Wernicke's encephalopathy (WE), is an acute neurologic disorder."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_192641002","Thiamine can deplete rapidly in CD and UC, which can lead to Wernicke's encephalopathy (WE), is an acute neurologic disorder."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_267679005","Thiamine can deplete rapidly in CD and UC, which can lead to Wernicke's encephalopathy (WE), is an acute neurologic disorder."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_155053002","Thiamine can deplete rapidly in CD and UC, which can lead to Wernicke's encephalopathy (WE), is an acute neurologic disorder."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_76011009","Thiamine can deplete rapidly in CD and UC, which can lead to Wernicke's encephalopathy (WE), is an acute neurologic disorder."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_81308009","Thiamine can deplete rapidly in CD and UC, which can lead to Wernicke's encephalopathy (WE), is an acute neurologic disorder."
"https://www.kegg.jp/entry/C00378","http://www.ihtsdo.org/SCT_193051008","Thiamine can deplete rapidly in CD and UC, which can lead to Wernicke's encephalopathy (WE), is an acute neurologic disorder."
"https://www.kegg.jp/entry/C00072","http://www.ihtsdo.org/SCT_312514006","Ascorbate concentrations were positively correlated with ferritin concentrations in Caco-2 cells - an accurate predictor of Fe bioavailability in human digestion - exposed to &gt;i&lt;in vitro&gt;/i&lt; digests of NS and 35S-&gt;i&lt;OsGGP&gt;/i&lt; BR and GBR samples."
"https://www.kegg.jp/entry/C00072","http://www.ihtsdo.org/SCT_34638006","Ascorbate concentrations were positively correlated with ferritin concentrations in Caco-2 cells - an accurate predictor of Fe bioavailability in human digestion - exposed to &gt;i&lt;in vitro&gt;/i&lt; digests of NS and 35S-&gt;i&lt;OsGGP&gt;/i&lt; BR and GBR samples."
"https://www.kegg.jp/entry/C00072","http://www.ihtsdo.org/SCT_54336006","Ascorbate concentrations were positively correlated with ferritin concentrations in Caco-2 cells - an accurate predictor of Fe bioavailability in human digestion - exposed to &gt;i&lt;in vitro&gt;/i&lt; digests of NS and 35S-&gt;i&lt;OsGGP&gt;/i&lt; BR and GBR samples."
"https://www.kegg.jp/entry/C00072","http://www.ihtsdo.org/SCT_205555008","Ascorbate concentrations were positively correlated with ferritin concentrations in Caco-2 cells - an accurate predictor of Fe bioavailability in human digestion - exposed to &gt;i&lt;in vitro&gt;/i&lt; digests of NS and 35S-&gt;i&lt;OsGGP&gt;/i&lt; BR and GBR samples."
"https://www.kegg.jp/entry/C00072","http://www.ihtsdo.org/SCT_239058007","Ascorbate concentrations were positively correlated with ferritin concentrations in Caco-2 cells - an accurate predictor of Fe bioavailability in human digestion - exposed to &gt;i&lt;in vitro&gt;/i&lt; digests of NS and 35S-&gt;i&lt;OsGGP&gt;/i&lt; BR and GBR samples."
"https://www.kegg.jp/entry/C00072","http://www.ihtsdo.org/SCT_254127001","Ascorbate concentrations were positively correlated with ferritin concentrations in Caco-2 cells - an accurate predictor of Fe bioavailability in human digestion - exposed to &gt;i&lt;in vitro&gt;/i&lt; digests of NS and 35S-&gt;i&lt;OsGGP&gt;/i&lt; BR and GBR samples."
"https://www.kegg.jp/entry/C00072","http://www.ihtsdo.org/SCT_258699004","Ascorbate concentrations were positively correlated with ferritin concentrations in Caco-2 cells - an accurate predictor of Fe bioavailability in human digestion - exposed to &gt;i&lt;in vitro&gt;/i&lt; digests of NS and 35S-&gt;i&lt;OsGGP&gt;/i&lt; BR and GBR samples."
"https://www.kegg.jp/entry/C00072","http://www.ihtsdo.org/SCT_359766000","Ascorbate concentrations were positively correlated with ferritin concentrations in Caco-2 cells - an accurate predictor of Fe bioavailability in human digestion - exposed to &gt;i&lt;in vitro&gt;/i&lt; digests of NS and 35S-&gt;i&lt;OsGGP&gt;/i&lt; BR and GBR samples."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_10200004","Glycine concentrations in serum and liver were markedly lower in obese versus lean rats."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_155807008","Glycine concentrations in serum and liver were markedly lower in obese versus lean rats."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_155817003","Glycine concentrations in serum and liver were markedly lower in obese versus lean rats."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_155822003","Glycine concentrations in serum and liver were markedly lower in obese versus lean rats."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_197375001","Glycine concentrations in serum and liver were markedly lower in obese versus lean rats."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_197551000","Glycine concentrations in serum and liver were markedly lower in obese versus lean rats."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_235856003","Glycine concentrations in serum and liver were markedly lower in obese versus lean rats."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_266535008","Glycine concentrations in serum and liver were markedly lower in obese versus lean rats."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_62857009","Glycine concentrations in serum and liver were markedly lower in obese versus lean rats."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_412238008","Glycine concentrations in serum and liver were markedly lower in obese versus lean rats."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_88566002","Glycine concentrations in serum and liver were markedly lower in obese versus lean rats."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_414916001","Glycine concentrations in serum and liver were markedly lower in obese versus lean rats."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_154776002","Glycine concentrations in serum and liver were markedly lower in obese versus lean rats."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_190963004","Glycine concentrations in serum and liver were markedly lower in obese versus lean rats."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_414915002","Glycine concentrations in serum and liver were markedly lower in obese versus lean rats."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_5476005","Glycine concentrations in serum and liver were markedly lower in obese versus lean rats."
"https://www.kegg.jp/entry/C00255","http://www.ihtsdo.org/SCT_79514008","Riboflavin supplementation alters global and gene-specific DNA methylation in adults with the MTHFR 677 TT genotype"
"https://www.kegg.jp/entry/C00255","http://www.ihtsdo.org/SCT_41797007","Riboflavin supplementation alters global and gene-specific DNA methylation in adults with the MTHFR 677 TT genotype"
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_237055002","Homocysteine concentrations in nonobese patients with polycystic ovarian syndrome (PCOS) were lower than obese patients with PCOS (SMD = 0.48, 95% CI = 0.20-0.77, P &lt; .01; I&gt;sup&lt;2 &gt;/sup&lt; = 39% and P = .18 for heterogeneity)."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_69878008","Homocysteine concentrations in nonobese patients with polycystic ovarian syndrome (PCOS) were lower than obese patients with PCOS (SMD = 0.48, 95% CI = 0.20-0.77, P &lt; .01; I&gt;sup&lt;2 &gt;/sup&lt; = 39% and P = .18 for heterogeneity)."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_154714009","Homocysteine concentrations in nonobese patients with polycystic ovarian syndrome (PCOS) were lower than obese patients with PCOS (SMD = 0.48, 95% CI = 0.20-0.77, P &lt; .01; I&gt;sup&lt;2 &gt;/sup&lt; = 39% and P = .18 for heterogeneity)."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_190549002","Homocysteine concentrations in nonobese patients with polycystic ovarian syndrome (PCOS) were lower than obese patients with PCOS (SMD = 0.48, 95% CI = 0.20-0.77, P &lt; .01; I&gt;sup&lt;2 &gt;/sup&lt; = 39% and P = .18 for heterogeneity)."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_237792009","Homocysteine concentrations in nonobese patients with polycystic ovarian syndrome (PCOS) were lower than obese patients with PCOS (SMD = 0.48, 95% CI = 0.20-0.77, P &lt; .01; I&gt;sup&lt;2 &gt;/sup&lt; = 39% and P = .18 for heterogeneity)."
"https://www.kegg.jp/entry/C00155","http://www.ihtsdo.org/SCT_271199009","Homocysteine concentrations in nonobese patients with polycystic ovarian syndrome (PCOS) were lower than obese patients with PCOS (SMD = 0.48, 95% CI = 0.20-0.77, P &lt; .01; I&gt;sup&lt;2 &gt;/sup&lt; = 39% and P = .18 for heterogeneity)."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_154722002","What is Known: • Folic acid is an essential micronutrient for optimal growth and development; its deficit is associated with adverse health effects."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_154730001","What is Known: • Folic acid is an essential micronutrient for optimal growth and development; its deficit is associated with adverse health effects."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_190595009","What is Known: • Folic acid is an essential micronutrient for optimal growth and development; its deficit is associated with adverse health effects."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_190608007","What is Known: • Folic acid is an essential micronutrient for optimal growth and development; its deficit is associated with adverse health effects."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_190678008","What is Known: • Folic acid is an essential micronutrient for optimal growth and development; its deficit is associated with adverse health effects."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_238106006","What is Known: • Folic acid is an essential micronutrient for optimal growth and development; its deficit is associated with adverse health effects."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_248325000","What is Known: • Folic acid is an essential micronutrient for optimal growth and development; its deficit is associated with adverse health effects."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_2492009","What is Known: • Folic acid is an essential micronutrient for optimal growth and development; its deficit is associated with adverse health effects."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_267409003","What is Known: • Folic acid is an essential micronutrient for optimal growth and development; its deficit is associated with adverse health effects."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_267495004","What is Known: • Folic acid is an essential micronutrient for optimal growth and development; its deficit is associated with adverse health effects."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_302868002","What is Known: • Folic acid is an essential micronutrient for optimal growth and development; its deficit is associated with adverse health effects."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_47563007","What is Known: • Folic acid is an essential micronutrient for optimal growth and development; its deficit is associated with adverse health effects."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_65404009","What is Known: • Folic acid is an essential micronutrient for optimal growth and development; its deficit is associated with adverse health effects."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_70241007","What is Known: • Folic acid is an essential micronutrient for optimal growth and development; its deficit is associated with adverse health effects."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_64572001","Leucine-rich alpha 2 glycoprotein is a new marker for active disease of tuberculosis"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_373576009","Leucine-rich alpha 2 glycoprotein is a new marker for active disease of tuberculosis"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_56717001","Leucine-rich alpha 2 glycoprotein is a new marker for active disease of tuberculosis"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_154281007","Leucine-rich alpha 2 glycoprotein is a new marker for active disease of tuberculosis"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_154292008","Leucine-rich alpha 2 glycoprotein is a new marker for active disease of tuberculosis"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_186282009","Leucine-rich alpha 2 glycoprotein is a new marker for active disease of tuberculosis"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_187285000","Leucine-rich alpha 2 glycoprotein is a new marker for active disease of tuberculosis"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_263912007","Leucine-rich alpha 2 glycoprotein is a new marker for active disease of tuberculosis"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_371569005","Leucine-rich alpha 2 glycoprotein is a new marker for active disease of tuberculosis"
"https://www.kegg.jp/entry/C00369","http://www.ihtsdo.org/SCT_269652000","Starch may change from typical single endotherm to biphasic endotherm (G1, G2) by HMT which corresponded to two viscosity peaks (PV&gt;sub&lt;1&gt;/sub&lt; and PV&gt;sub&lt;2&gt;/sub&lt;) in pasting analysis."
"https://www.kegg.jp/entry/C00369","http://www.ihtsdo.org/SCT_278190000","Starch may change from typical single endotherm to biphasic endotherm (G1, G2) by HMT which corresponded to two viscosity peaks (PV&gt;sub&lt;1&gt;/sub&lt; and PV&gt;sub&lt;2&gt;/sub&lt;) in pasting analysis."
"https://www.kegg.jp/entry/C00369","http://www.ihtsdo.org/SCT_31569001","Starch may change from typical single endotherm to biphasic endotherm (G1, G2) by HMT which corresponded to two viscosity peaks (PV&gt;sub&lt;1&gt;/sub&lt; and PV&gt;sub&lt;2&gt;/sub&lt;) in pasting analysis."
"https://www.kegg.jp/entry/C00369","http://www.ihtsdo.org/SCT_134182002","Starch may change from typical single endotherm to biphasic endotherm (G1, G2) by HMT which corresponded to two viscosity peaks (PV&gt;sub&lt;1&gt;/sub&lt; and PV&gt;sub&lt;2&gt;/sub&lt;) in pasting analysis."
"https://www.kegg.jp/entry/C00369","http://www.ihtsdo.org/SCT_154644004","Starch may change from typical single endotherm to biphasic endotherm (G1, G2) by HMT which corresponded to two viscosity peaks (PV&gt;sub&lt;1&gt;/sub&lt; and PV&gt;sub&lt;2&gt;/sub&lt;) in pasting analysis."
"https://www.kegg.jp/entry/C00369","http://www.ihtsdo.org/SCT_109992005","Starch may change from typical single endotherm to biphasic endotherm (G1, G2) by HMT which corresponded to two viscosity peaks (PV&gt;sub&lt;1&gt;/sub&lt; and PV&gt;sub&lt;2&gt;/sub&lt;) in pasting analysis."
"https://www.kegg.jp/entry/C00369","http://www.ihtsdo.org/SCT_128841001","Starch may change from typical single endotherm to biphasic endotherm (G1, G2) by HMT which corresponded to two viscosity peaks (PV&gt;sub&lt;1&gt;/sub&lt; and PV&gt;sub&lt;2&gt;/sub&lt;) in pasting analysis."
"https://www.kegg.jp/entry/C00369","http://www.ihtsdo.org/SCT_7378008","Starch may change from typical single endotherm to biphasic endotherm (G1, G2) by HMT which corresponded to two viscosity peaks (PV&gt;sub&lt;1&gt;/sub&lt; and PV&gt;sub&lt;2&gt;/sub&lt;) in pasting analysis."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_197321007","Results: Folic acid treatment attenuated steatosis, lobular inflammation, and hepatocellular ballooning in rats with HFD-induced steatohepatitis."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_442191002","Results: Folic acid treatment attenuated steatosis, lobular inflammation, and hepatocellular ballooning in rats with HFD-induced steatohepatitis."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_190803000","Results: Folic acid treatment attenuated steatosis, lobular inflammation, and hepatocellular ballooning in rats with HFD-induced steatohepatitis."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_29185008","Results: Folic acid treatment attenuated steatosis, lobular inflammation, and hepatocellular ballooning in rats with HFD-induced steatohepatitis."
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_197321007","Folic acid attenuates high-fat diet-induced steatohepatitis via deacetylase SIRT1-dependent restoration of PPARα"
"https://www.kegg.jp/entry/C00504","http://www.ihtsdo.org/SCT_442191002","Folic acid attenuates high-fat diet-induced steatohepatitis via deacetylase SIRT1-dependent restoration of PPARα"
"https://www.kegg.jp/entry/C00369","http://www.ihtsdo.org/SCT_42402006","Starch-guest ICs has a great potential to be a delivery system, as most existing studies demonstrated the enhancement on guest retention and the possibility of controlled release."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_414916001","Novel Cardioprotective Effect of L-Carnitine on Obese Diabetic Mice: Regulation of Chemerin and CMKLRI Expression in Heart and Adipose Tissues"
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_154776002","Novel Cardioprotective Effect of L-Carnitine on Obese Diabetic Mice: Regulation of Chemerin and CMKLRI Expression in Heart and Adipose Tissues"
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_190963004","Novel Cardioprotective Effect of L-Carnitine on Obese Diabetic Mice: Regulation of Chemerin and CMKLRI Expression in Heart and Adipose Tissues"
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_414915002","Novel Cardioprotective Effect of L-Carnitine on Obese Diabetic Mice: Regulation of Chemerin and CMKLRI Expression in Heart and Adipose Tissues"
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_5476005","Novel Cardioprotective Effect of L-Carnitine on Obese Diabetic Mice: Regulation of Chemerin and CMKLRI Expression in Heart and Adipose Tissues"
"https://www.kegg.jp/entry/C00062","http://www.ihtsdo.org/SCT_33316007","L-Arginine Ameliorates Defective Autophagy in GM2 Gangliosidoses by mTOR Modulation"
"https://www.kegg.jp/entry/C00794","http://www.ihtsdo.org/SCT_28724005","Sorbitol was the most commonly used LCS (2.9%)."
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_266171003","L-Carnitine Tartrate Downregulates the ACE2 Receptor and Limits SARS-CoV-2 Infection"
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_35500006","L-Carnitine Tartrate Downregulates the ACE2 Receptor and Limits SARS-CoV-2 Infection"
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_367443006","L-Carnitine Tartrate Downregulates the ACE2 Receptor and Limits SARS-CoV-2 Infection"
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_40733004","L-Carnitine Tartrate Downregulates the ACE2 Receptor and Limits SARS-CoV-2 Infection"
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_189822004","L-Carnitine Tartrate Downregulates the ACE2 Receptor and Limits SARS-CoV-2 Infection"
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_190563008","L-Carnitine Tartrate Downregulates the ACE2 Receptor and Limits SARS-CoV-2 Infection"
"https://www.kegg.jp/entry/C00318","http://www.ihtsdo.org/SCT_191415002","L-Carnitine Tartrate Downregulates the ACE2 Receptor and Limits SARS-CoV-2 Infection"
"https://www.kegg.jp/entry/C05441","http://www.ihtsdo.org/SCT_124886009","Vitamin D2 may play a role in preventing vitamin D deficiency in Chinese children aged 3-5 years."
"https://www.kegg.jp/entry/C05441","http://www.ihtsdo.org/SCT_154728003","Vitamin D2 may play a role in preventing vitamin D deficiency in Chinese children aged 3-5 years."
"https://www.kegg.jp/entry/C05441","http://www.ihtsdo.org/SCT_190639009","Vitamin D2 may play a role in preventing vitamin D deficiency in Chinese children aged 3-5 years."
"https://www.kegg.jp/entry/C05441","http://www.ihtsdo.org/SCT_190649007","Vitamin D2 may play a role in preventing vitamin D deficiency in Chinese children aged 3-5 years."
"https://www.kegg.jp/entry/C05441","http://www.ihtsdo.org/SCT_34713006","Vitamin D2 may play a role in preventing vitamin D deficiency in Chinese children aged 3-5 years."
"https://www.kegg.jp/entry/C00078","http://www.ihtsdo.org/SCT_64226004","Dietary L-Tryptophan Regulates Colonic Serotonin Homeostasis in Mice with Dextran Sodium Sulfate-Induced Colitis"
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_80633008","Chlorogenic Acid Decreases Glutamate Release from Rat Cortical Nerve Terminals by P/Q-Type Ca 2+ Channel Suppression: A Possible Neuroprotective Mechanism"
"https://www.kegg.jp/entry/C00025","http://www.ihtsdo.org/SCT_193659009","Chlorogenic Acid Decreases Glutamate Release from Rat Cortical Nerve Terminals by P/Q-Type Ca 2+ Channel Suppression: A Possible Neuroprotective Mechanism"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_155023009","NO x-, IL-1β-, TNF-α-, and IL-6-Inhibiting Effects and Trypanocidal Activity of Banana ( Musa acuminata) Bracts and Flowers: UPLC-HRESI-MS Detection of Phenylpropanoid Sucrose Esters"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_192928003","NO x-, IL-1β-, TNF-α-, and IL-6-Inhibiting Effects and Trypanocidal Activity of Banana ( Musa acuminata) Bracts and Flowers: UPLC-HRESI-MS Detection of Phenylpropanoid Sucrose Esters"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_192930001","NO x-, IL-1β-, TNF-α-, and IL-6-Inhibiting Effects and Trypanocidal Activity of Banana ( Musa acuminata) Bracts and Flowers: UPLC-HRESI-MS Detection of Phenylpropanoid Sucrose Esters"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_24700007","NO x-, IL-1β-, TNF-α-, and IL-6-Inhibiting Effects and Trypanocidal Activity of Banana ( Musa acuminata) Bracts and Flowers: UPLC-HRESI-MS Detection of Phenylpropanoid Sucrose Esters"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_146504006","NO x-, IL-1β-, TNF-α-, and IL-6-Inhibiting Effects and Trypanocidal Activity of Banana ( Musa acuminata) Bracts and Flowers: UPLC-HRESI-MS Detection of Phenylpropanoid Sucrose Esters"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_8959002","NO x-, IL-1β-, TNF-α-, and IL-6-Inhibiting Effects and Trypanocidal Activity of Banana ( Musa acuminata) Bracts and Flowers: UPLC-HRESI-MS Detection of Phenylpropanoid Sucrose Esters"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_279351001","NO x-, IL-1β-, TNF-α-, and IL-6-Inhibiting Effects and Trypanocidal Activity of Banana ( Musa acuminata) Bracts and Flowers: UPLC-HRESI-MS Detection of Phenylpropanoid Sucrose Esters"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_258697002","NO x-, IL-1β-, TNF-α-, and IL-6-Inhibiting Effects and Trypanocidal Activity of Banana ( Musa acuminata) Bracts and Flowers: UPLC-HRESI-MS Detection of Phenylpropanoid Sucrose Esters"
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_64226004","Pomegranate Extract Improves Colitis in IL-10 Knockout Mice Fed a High Fat High Sucrose Diet"
"https://www.kegg.jp/entry/C00864","http://www.ihtsdo.org/SCT_414916001","Pantothenate, formic acid and glycine were downregulated by obesity, while formic acid, dimethylamine and galactose were downregulated in pre-GDM."
"https://www.kegg.jp/entry/C00864","http://www.ihtsdo.org/SCT_154776002","Pantothenate, formic acid and glycine were downregulated by obesity, while formic acid, dimethylamine and galactose were downregulated in pre-GDM."
"https://www.kegg.jp/entry/C00864","http://www.ihtsdo.org/SCT_190963004","Pantothenate, formic acid and glycine were downregulated by obesity, while formic acid, dimethylamine and galactose were downregulated in pre-GDM."
"https://www.kegg.jp/entry/C00864","http://www.ihtsdo.org/SCT_414915002","Pantothenate, formic acid and glycine were downregulated by obesity, while formic acid, dimethylamine and galactose were downregulated in pre-GDM."
"https://www.kegg.jp/entry/C00864","http://www.ihtsdo.org/SCT_5476005","Pantothenate, formic acid and glycine were downregulated by obesity, while formic acid, dimethylamine and galactose were downregulated in pre-GDM."
"https://www.kegg.jp/entry/C00864","http://www.ihtsdo.org/SCT_199232003","Pantothenate, formic acid and glycine were downregulated by obesity, while formic acid, dimethylamine and galactose were downregulated in pre-GDM."
"https://www.kegg.jp/entry/C00864","http://www.ihtsdo.org/SCT_237629002","Pantothenate, formic acid and glycine were downregulated by obesity, while formic acid, dimethylamine and galactose were downregulated in pre-GDM."
"https://www.kegg.jp/entry/C00864","http://www.ihtsdo.org/SCT_359964007","Pantothenate, formic acid and glycine were downregulated by obesity, while formic acid, dimethylamine and galactose were downregulated in pre-GDM."
"https://www.kegg.jp/entry/C00864","http://www.ihtsdo.org/SCT_393568003","Pantothenate, formic acid and glycine were downregulated by obesity, while formic acid, dimethylamine and galactose were downregulated in pre-GDM."
"https://www.kegg.jp/entry/C00864","http://www.ihtsdo.org/SCT_11687002","Pantothenate, formic acid and glycine were downregulated by obesity, while formic acid, dimethylamine and galactose were downregulated in pre-GDM."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_235907000","Sucrose as the carbon source, (NH&gt;sub&lt;4&gt;/sub&lt;)&gt;sub&lt;2&gt;/sub&lt;HPO&gt;sub&lt;4&gt;/sub&lt; as the nitrogen source, CaCl&gt;sub&lt;2&gt;/sub&lt; as the metal ion were obtained."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_6160004","Sucrose as the carbon source, (NH&gt;sub&lt;4&gt;/sub&lt;)&gt;sub&lt;2&gt;/sub&lt;HPO&gt;sub&lt;4&gt;/sub&lt; as the nitrogen source, CaCl&gt;sub&lt;2&gt;/sub&lt; as the metal ion were obtained."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_137664007","Sucrose as the carbon source, (NH&gt;sub&lt;4&gt;/sub&lt;)&gt;sub&lt;2&gt;/sub&lt;HPO&gt;sub&lt;4&gt;/sub&lt; as the nitrogen source, CaCl&gt;sub&lt;2&gt;/sub&lt; as the metal ion were obtained."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_14732006","Sucrose as the carbon source, (NH&gt;sub&lt;4&gt;/sub&lt;)&gt;sub&lt;2&gt;/sub&lt;HPO&gt;sub&lt;4&gt;/sub&lt; as the nitrogen source, CaCl&gt;sub&lt;2&gt;/sub&lt; as the metal ion were obtained."
"https://www.kegg.jp/entry/C00089","http://www.ihtsdo.org/SCT_160262006","Sucrose as the carbon source, (NH&gt;sub&lt;4&gt;/sub&lt;)&gt;sub&lt;2&gt;/sub&lt;HPO&gt;sub&lt;4&gt;/sub&lt; as the nitrogen source, CaCl&gt;sub&lt;2&gt;/sub&lt; as the metal ion were obtained."
"https://www.kegg.jp/entry/C01673","http://www.ihtsdo.org/SCT_363510005","Background: Calcitriol, the active form of vitamin D, may inhibit colorectal cancer (CRC) progression, which has been mechanistically linked to an attenuation of a pro-inflammatory state."
"https://www.kegg.jp/entry/C01673","http://www.ihtsdo.org/SCT_93854002","Background: Calcitriol, the active form of vitamin D, may inhibit colorectal cancer (CRC) progression, which has been mechanistically linked to an attenuation of a pro-inflammatory state."
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_154634001","Leucine-Rich Diet Improved Muscle Function in Cachectic Walker 256 Tumour-Bearing Wistar Rats"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_154645003","Leucine-Rich Diet Improved Muscle Function in Cachectic Walker 256 Tumour-Bearing Wistar Rats"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_154646002","Leucine-Rich Diet Improved Muscle Function in Cachectic Walker 256 Tumour-Bearing Wistar Rats"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_190230000","Leucine-Rich Diet Improved Muscle Function in Cachectic Walker 256 Tumour-Bearing Wistar Rats"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_187597000","Leucine-Rich Diet Improved Muscle Function in Cachectic Walker 256 Tumour-Bearing Wistar Rats"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_108369006","Leucine-Rich Diet Improved Muscle Function in Cachectic Walker 256 Tumour-Bearing Wistar Rats"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_189542002","Leucine-Rich Diet Improved Muscle Function in Cachectic Walker 256 Tumour-Bearing Wistar Rats"
"https://www.kegg.jp/entry/C16439","http://www.ihtsdo.org/SCT_86251006","Leucine-Rich Diet Improved Muscle Function in Cachectic Walker 256 Tumour-Bearing Wistar Rats"
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_64226004","Conclusions: Glycine supplementation is a nutritional strategy that may ameliorate C. rodentium-induced colitis by regulating ATF6α-CHOP-mediated ER stress and enhancing the abundance of Lactobacillus."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_64226004","Glycine supplementation is reported to reduce inflammatory responses in experimental colitis."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_263977005","Glycine suppresses the activation and infiltration of inflammatory cells, and secretion of pro-inflammatory cytokines in the colon tissues."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_71854001","Glycine suppresses the activation and infiltration of inflammatory cells, and secretion of pro-inflammatory cytokines in the colon tissues."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_128524007","Glycine suppresses the activation and infiltration of inflammatory cells, and secretion of pro-inflammatory cytokines in the colon tissues."
"https://www.kegg.jp/entry/C00037","http://www.ihtsdo.org/SCT_64226004","Glycine Attenuates Citrobacter rodentium-Induced Colitis by Regulating ATF6-Mediated Endoplasmic Reticulum Stress in Mice"